Artificial heart valves with improved sealing devices
By designing a medical implant with a compressible and expandable stent structure and inner and outer skirt components, the problems of excessively large delivery diameter and poor sealing in existing heart valve technologies have been solved, achieving safe and reliable minimally invasive heart valve replacement and sealing.
Patent Information
- Application Number
- CN202180056402.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-10-30
- Filing Date
- 2021-06-09
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2041-06-09
AI Technical Summary
Existing transcatheter heart valves are too large in diameter during delivery, resulting in a high risk of damage and poor sealing, which can easily lead to perivalvular leakage and affect heart function.
A medical implant comprising a stent structure and a skirt element has been designed. The stent structure is compressible and expandable, and the skirt element includes inner and outer skirts. The inner skirt covers the inside of the stent, and the outer skirt covers the outside. The valve leaflets are connected to the stent via syndesmoid posts to form a sealed structure that adapts to the cardiac anatomy and reduces leakage.
It achieves small-diameter delivery without damage, ensures a tight seal, reduces perivalvular leakage, improves cardiac function stability, and reduces the risk of complications.
Smart Images

Figure CN115996691B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to a medical implant, such as, but not limited to, vascular implants, preferably catheter-deliverable internal prostheses, such as artificial venous valves or artificial heart valves for valve replacement, comprising one or more leaflet tissue components and one or more skirt elements, allowing reliable valve function and a suitable sealing device to prevent perivalvular leakage, particularly for aortic valves. The invention also relates to a medical implant, such as, but not limited to, catheter-deliverable internal prostheses, such as artificial heart valves for treating stenotic heart valves and / or valvular insufficiency, such as transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI). Artificial heart valves may also be referred to as stent valves or valved stents. Background Technology
[0002] Traditional methods for heart valve replacement require relatively large incisions in the patient's sternum ("sternotomy") or pleural cavity ("thoracotomy") to allow surgeons access to the patient's heart. Furthermore, these methods require stopping the patient's heart and using a cardiopulmonary bypass (i.e., using a cardiopulmonary bypass machine to oxygenate and circulate the patient's blood). In recent years, efforts have been made to establish a less invasive approach to heart valve replacement surgery via a transvascular approach, delivering and implanting a new valve through a catheter inserted through a smaller skin incision; that is, delivering the new valve via the femoral artery or a transapical approach, where the replacement valve is delivered between the ribs and directly through the heart wall to the implantation site.
[0003] Stent valves and delivery systems for placing replacement valves via catheters are known in the art and disclosed, for example, in WO2007 / 071436 and WO2009 / 053497. Some known stents are made of shape memory materials, such as nitinol, and are self-expanding. Valves may be derived from animals, such as porcine aortic valves. Alternatively, valves may be made at least partially of synthetic materials, such as Dacron.
[0004] Minimally invasive procedures for implanting medical devices are now quite common and allow for implantation under local anesthesia. One approach provides the use of a catheter system to introduce a medical implant comprising a supporting scaffold structure (stent) and leaflets.
[0005] This implant can be rolled up and then guided to the implantation site in a compressed state via a catheter system, such as through the inguinal artery or vein in the heart. Once it reaches the implantation site, the medical implant can be unfolded.
[0006] For example, WO2007 / 071436 discloses an artificial heart valve comprising a valve element and a stent element. The stent element comprises three distinct parts, one of which houses the valve element. The valve element comprises three leaflets, which may be made of biological or artificial materials. The three distinct parts may have different diameters. Other artificial heart valves are described in documents WO2011 / 147849A1 and US2017 / 0065408A1.
[0007] A major drawback of some known replacement valve stents is that, even in a collapsed (curled) state, their diameter is often too large for transvascular delivery. When the stent must be advanced over the aortic arch, transfemoral delivery requires even smaller diameters, such as 18 French or less (18F equals 6 mm). This smaller diameter is also useful for transapical delivery if smaller skin incisions and / or smaller incisions in the heart wall can be made.
[0008] Rolling some known stent valves to a diameter of, for example, 18 French or smaller, can create high strain on the replacement valve, which can lead to damage.
[0009] Therefore, artificial heart valves are needed that avoid the drawbacks of known valves, and in particular, can be rolled into small diameters without the risk of damaging the replacement valve, and can be reliably placed and firmly anchored to the aortic valve annulus.
[0010] Another problem with medical implants (such as transcatheter deliverable internal prostheses, preferably artificial heart valves) is the sealing of the anatomical structures at the implantation site. For example, perivalvular leakage (PVL) is a major drawback of current transcatheter artificial heart valves. Perivalvular or periprosthetic leakage refers to the passage of blood through the implanted medical implant component of the transcatheter heart valve and the patient's anatomy at the implantation site (e.g., the natural aortic rings) due to inadequate sealing. In the case of aortic valve replacement, chronic backflow of blood leads to volume overload of the left ventricle. Adverse events resulting from this include tachypnea, atrial fibrillation, and other symptoms commonly associated with heart failure, including increased mortality. Therefore, minimizing or avoiding PVL is a major focus of TAVI development. Advanced sealing strategies are feasible solutions for reducing or even preventing TAVI-related PVL.
[0011] Most known sealing concepts simply consist of a flat pericardial or fabric band firmly anchored to the inflow portion of the prosthesis (i.e., the prosthesis portion typically contacts the cardiac annulus / natural leaflet). Some more complex concepts utilize slack or pockets. Known solutions are partially or not always able to reach / fill the notch or groove or gap and channel between the natural aortic valve annulus and the medical implant. Other existing solutions, in which additional material is voluntarily added to fill these gaps, must sacrifice the overall curvature profile of the prosthesis.
[0012] Therefore, there is a need for medical implants that avoid these drawbacks, such as catheter-deliverable internal prostheses, preferably artificial heart valves. Summary of the Invention
[0013] This is achieved by a medical implant having the features of claim 1. Advantageous embodiments of the invention are specified in the corresponding dependent claims.
[0014] A medical implant, such as, but not limited to, a vascular implant, preferably a catheter-deliverable internal prosthesis, such as an artificial venous valve or an artificial heart valve, is described. The artificial heart valve may be an aortic, mitral, tricuspid, or pulmonary artery artificial heart valve.
[0015] Medical implants include a scaffold structure (hereinafter also referred to as a scaffold structure or scaffold component) and one or more skirts. The scaffold structure has a longitudinal axis and a circumference around an internal volume (cavity) and the longitudinal axis.
[0016] A skirt at least partially covers the outer side of the support structure and optionally extends at least partially to the outside of the support structure, preferably extending radially outward along the circumference of the support structure. A skirt may be an inner skirt (also referred to as an inner skirt element) and / or a skirt may be an outer skirt (also referred to as an outer skirt element). Alternatively, a skirt that at least partially covers the outer side of the support structure also at least partially covers the inner side of the support structure. The inner skirt has a first inner skirt edge and a second inner skirt edge (opposite to the first skirt edge). The outer skirt has a first outer skirt edge and a second outer skirt edge (opposite to the first skirt edge).
[0017] The scaffold structure is an open scaffold structure, preferably cylindrical or tubular. In this case, the circumference is considered to be the perimeter. Medical implants may include compressible and expandable scaffold structures (allowing the medical implant to be delivered to the implantation site using a catheter). Therefore, the scaffold structure can have a compressible (delivery) state and can expand into a functional state.
[0018] At least a portion of the stent structure, the inner skirt and / or outer skirt, and optional valve components form an implant component. The medical implant component defines a flow channel for guiding and / or controlling the flow of fluids (e.g., blood flow). The flow channel has an inflow end and an outflow end. Bodily fluids, such as blood, flow through the flow channel in one flow direction, from the (proximal) inflow end to the (opposite) outflow end. The inner skirt may be surrounded by the stent structure. The stent structure may be surrounded by the outer skirt.
[0019] The support structure has a (proximal) inflow portion and an outflow portion, as well as at least one intermediate portion (also referred to as a transition zone) disposed between the inflow and outflow portions. The support structure has a first support structure end and a second support structure end. The first support structure end and / or the (proximal) inflow portion may be located at the inflow end of the flow channel, or the first support structure end may be located spaced apart from the inflow end of the flow channel (when viewed along the longitudinal axis). The second support structure end and / or the outflow portion may be located at the outflow end of the flow channel, or the second support structure end may be located spaced apart from the outflow end of the flow channel (when viewed along the longitudinal axis).
[0020] The second stent structure end is opposite the first stent structure end (when viewed along the longitudinal axis). Therefore, when implanted as intended, bodily fluids first pass through the first stent structure end.
[0021] Medical implants or implant components may include valve assemblies. A valve assembly may include one or more valve leaflets (hereinafter referred to as leaflets), preferably at least two or three leaflets. Preferably, the flow channel of the medical implant component may include at least one or at least two leaflets within the flow channel. The leaflets have a flow control function, allowing fluid to flow in a first direction (from the inflow end to the outflow end) but preventing fluid from flowing in a second direction opposite to the first direction. The valve assembly may be surrounded by a stent structure.
[0022] The support structure comprises multiple units, preferably formed by multiple pillars.
[0023] At least a portion of the unit and an optional outer skirt form the external outline of the medical implant.
[0024] The present invention provides an artificial heart valve comprising a stent structure, characterized by a conical inflow portion, a cylindrical outflow portion, and a transition region connecting the inflow and outflow portions, the transition region having appropriately large units for free access to the coronary artery, and further comprising a valve assembly particularly suited to the stent structure by means of appropriate leaflets and skirt configuration.
[0025] The various aspects and embodiments of the invention are further defined below, which can be derived from the accompanying drawings and are specifically outlined in the description of the drawings.
[0026] A key aspect of the present invention provides an artificial heart valve for heart valve replacement, comprising a valve assembly (and / or tissue valve) having one or more leaflets, preferably two or more leaflets, more preferably exactly three leaflets. As used herein, the term "valve assembly" refers collectively to leaflets, regardless of whether the leaflets are fixed together to define an integral valve structure independent of other components.
[0027] According to the invention, the leaflets are made of pericardial tissue, preferably from porcine or bovine pericardium. Porcine pericardium may be ideally thin and durable enough. Bovine pericardium may be thicker and even more durable if desired. In one embodiment, each valve leaflet includes at least two tabs. In embodiments of the invention involving laser-assisted suturing (L-ASP), an exception is made, requiring only two tabs on the valve structure.
[0028] The artificial heart valve also includes a stent structure configured to be radially compressible into a compressed state and expandable into a functional state. The stent component includes a proximal conical inlet end and a cylindrical outlet end, and at least one intermediate portion disposed between the inlet and outlet portions, which serves as a transition zone. The intermediate portion (transition zone) has at least two connecting posts, optionally and / or generally aligned parallel to an axis from the inlet to the outlet end. Leaflet flaps are directly attached to the connecting posts, preferably to attachment devices, such as one or more through-holes, disposed on the connecting posts.
[0029] The construction and dimensional characteristics of the valve leaflets enable the formation of a functional replacement valve and are suitable for integration into the stent structure of the present invention. In some embodiments, the leaflet has a straight or slightly curved upper free edge, two lateral edges, and a generally arched lower edge. At least one tab is disposed on each lateral edge, preferably in the region of the upper free edge of the leaflet.
[0030] In the artificial heart valve of the present invention, at least one, preferably at least two, more preferably at least three leaflets are positioned such that their upper free edges can be pressed together to prevent blood from flowing in one direction, for example, during diastole in the case of aortic valve replacement, toward the heart, and moved apart to allow blood to flow in another direction, for example, away from the heart during systole.
[0031] In one embodiment, exactly three leaflets are provided. This allows for mimicking the structure of a natural tricuspid valve, such as the aortic valve. Alternatively, the artificial heart valve may also include more leaflets, such as four, five, or more.
[0032] While a wide variety of different artificial materials are known for use in valve replacement, it is preferred that at least two leaflets of the artificial heart valve according to the invention be made of pericardial tissue. In one embodiment, at least two leaflets are made of porcine pericardial tissue. Pericardial tissue is thin enough, yet also durable enough, to be used as the leaflet material. Porcine hearts share many similarities with human hearts. Therefore, the use of porcine pericardial tissue is advantageous. Furthermore, porcine pericardial tissue is readily available.
[0033] In one embodiment, calf pericarp can also be used for leaflets that require even greater durability, optionally at the expense of thicker tissue.
[0034] In one embodiment, the stent structure is self-expanding. Such stents are known in the art and typically comprise or are made of shape memory materials, such as nitinol. Alternatively, stent components may comprise or be made of malleable materials and can be expanded to a functional state by an external device, such as a balloon catheter.
[0035] In a compressed, for example, coiled state, the stent component can be inserted into the region of a patient's heart valve, such as the aortic valve. Furthermore, the diameter of the stent component in its compressed state allows it to be advanced into the patient's heart via an artery (e.g., the femoral artery). Therefore, the diameter and / or flexibility of the stent component in its compressed state preferably allow the artificial heart valve to advance through the aortic arch.
[0036] In its functional state, the stent structure is in at least a partially expanded or non-compressed configuration. Optionally, the stent structure defines an internal catheter space. The catheter space can typically be cylindrical and / or tubular. Valve leaflets are arranged to span the internal space within the stent structure. Once the artificial heart valve is positioned at a target location close to the patient's natural valve, the stent structure is expanded to its functional state.
[0037] The patient's natural valve leaflets can be pushed open by the dilated stent structure. Once fully dilated, the valve assembly arranged within the stent structure will take over the function of the natural valve.
[0038] In one embodiment, the valve assembly is disposed within the intermediate portion (transition zone) of the stent structure. In another embodiment, the valve assembly is disposed within the intermediate portion (transition zone) of the stent structure in a super-annular position. Optionally, the stent structure is configured such that the intermediate portion (transition zone) includes a tapered and / or cylindrical catheter space, optionally having a constant diameter.
[0039] In its functional state, the inflow and outflow portions of the stent structure define inflow and outflow openings through which blood can flow or around during use.
[0040] As understood herein, “inflow portion” refers to the portion of the stent structure into which blood enters the catheter space and / or the portion of the stent structure located upstream of the valve leaflet during use; for example, in the case of the semilunar valve and / or aortic valve, the portion of the stent structure facing the ventricle.
[0041] Therefore, the “outflow portion” as understood herein refers to the portion of the stent structure from which blood leaves the duct space and / or the portion of the stent structure located downstream of the valve leaflet during use; for example, the portion located in an artery for the semilunar valve.
[0042] The inflow and outflow portions can therefore have the same or different lengths. Furthermore, the inflow and / or outflow portions can define a generally tubular internal conduit space. This conduit space can typically be cylindrical. More preferably, the inflow and / or outflow portions comprise a generally conical conduit, i.e., a conduit with increasing or decreasing diameter. Alternatively, the inflow and outflow portions can comprise an internal conduit space of any suitable geometry.
[0043] Optionally, the inflow portion and the outflow portion may have the same maximum diameter or different maximum diameters. The term "maximum diameter" as understood herein refers to the maximum diameter within such a portion. Optionally, the inflow portion has a larger maximum diameter than the outflow portion. Furthermore, the diameter of the intermediate portion (transition zone) is smaller than the maximum diameter of either the inflow portion or the outflow portion. In another embodiment, the diameter of the intermediate portion (transition zone) may be equal to the diameter of the outflow portion. Alternatively, other portions may be arranged between the inflow and / or outflow portion and the intermediate portion.
[0044] Furthermore, the stent structure includes at least one attachment element for mating engagement with a delivery device (e.g., a stent holder of the delivery device). The at least one attachment element can be configured to restrict axial displacement of the stent component until the stent component is fully released. In some embodiments, at least one attachment element is disposed at the outflow portion. The stent structure may include any suitable number of attachment elements, such as two, three, or more, preferably three. More preferably, the three attachment elements are inclined inward toward the central axis of the stent structure. The attachment elements may be substantially uniformly spaced in the circumferential direction.
[0045] According to the present invention, the delivery catheter may include a stent retainer disposed within a stent receiving area. The stent retainer may include a corresponding protrusion that can be received within each orifice. The protrusion may be sized such that when the stent structure is in its retracted state, the protrusion is confined within the orifice and, at least in the retracted state of the stent components, cannot pass between adjacent struts and / or one or more recesses or gaps for substantially receiving attachment elements therein.
[0046] The above-described configuration provides a compact, reliable, and self-opening and / or self-releasing attachment between the stent valve and the delivery system. The provision of the attachment element also does not preclude the stent components from being compressed to the desired small size.
[0047] In some embodiments, the middle portion of the support structure includes at least two connecting posts, preferably three, typically aligned parallel to an axis from the inlet to the outlet. The leaflet tabs are directly attached to the connecting posts, preferably to attachment devices disposed on the connecting posts, such as one or more through-holes, preferably three through-holes.
[0048] The direct attachment of the leaflet to the syndesm provides the leaflet with high strain resistance. Optionally, compared to valve replacement stents known in the art, the direct connection between the leaflet and the syndesm can optionally reduce the thickness of the coiled stent element if excess tissue layers capable of withstanding strain resistance between the leaflet and the syndesm can be avoided.
[0049] The artificial heart valve of the present invention may further include an inner skirt element, preferably made of pericardial tissue, more preferably of porcine pericardium, and attached to the leaflets. The inner skirt element can be used to guide blood within the catheter space of the stent component and prevent blood leakage through the gaps in the stent component (e.g., through the grid-structured units).
[0050] In some embodiments, the inner skirt element may have a connecting portion separated by serrated gaps (e.g., serrated cuts). Each gap is spanned by a respective valve leaflet. The lateral and / or lower edges of the leaflets may be attached to the inner skirt, for example, by stitching.
[0051] In some embodiments, the inner skirt element may extend toward the second end, and the skirt is preferably sutured to the stent assembly. The skirt preferably at least partially covers the inner surface of the stent component. This reduces the occurrence of blood turbulence that may be caused by the material of the stent component. The skirt is preferably further sutured to the at least two valve leaflets.
[0052] Furthermore, at least a portion of the support structure is at least partially covered externally by an outer skirt element.
[0053] According to another aspect of the invention, an artificial heart valve for heart valve replacement is provided, comprising a stent structure having at least one portion defining at least a partially conical body. The device also has a plurality of valve leaflets. An inner skirt is disposed within the stent component and overlaps with the at least partially conical body to define a catheter therein. An outer skirt is disposed outside the stent component and overlaps only a portion of the at least partially conical body.
[0054] The inner skirt and / or outer skirt are preferably made of pericardial tissue, and most preferably of porcine pericardial tissue.
[0055] In all embodiments, at least one, preferably at least two, more preferably at least three leaflets are stitched to the connecting post through holes in the connecting post.
[0056] Another aspect of the present invention provides an artificial heart valve comprising a stent structure that is radially compressible to a compressed state for delivery and radially expandable to a functional state, a plurality of valve leaflets mounted within a stent component, an inner skirt element attached to the valve leaflets that extends at least partially within the stent component, and an outer skirt element that extends at least partially outside the stent component.
[0057] In some embodiments, the outer skirt element may extend further toward the inflow end of the support structure than the inner skirt element. Alternatively, the inner and outer skirts may partially overlap, at least with respect to the surface of at least one skirt. Alternatively, the inner and outer skirts may not have any connected ends. Alternatively, the inner skirt may extend further toward the outflow end of the support member than the outer skirt.
[0058] At least a portion of the support structure on which at least one skirt extends may optionally include a grid structure having at least one row of multiple units.
[0059] The function of the inner skirt element can be to define a conduit within the stent to direct blood to the valve leaflets and prevent blood leakage through gaps in the stent components (e.g., mesh gaps). The function of the outer skirt element can be to provide a sealing surface on the outside of the stent component for sealing with surrounding tissue to prevent leakage at the interface with surrounding tissue. Providing two skirts can be advantageous in terms of overall leakage prevention. The advantages of two skirts can be obtained by providing two skirts that only partially overlap in the axial direction, but with a reduced thickness profile in areas where only one skirt extends. The overlap of the skirts can provide a better seal between the skirts compared to the skirts being arranged side-by-side inside and outside the stent component (e.g., it should be particularly remembered that the stent valve will deform sufficiently by compression for delivery and re-expansion upon implantation).
[0060] The overlap of the skirt in the axial direction can be, for example, at least 1 mm, or at least 2 mm, or at least 3 mm, or at least 4 mm, or at least 5 mm, or at least 6 mm, or at least 7 mm, or at least 8 mm. Alternatively, the overlap of the skirt in the axial direction can be, for example, less than 10 mm, or less than 9 mm, or less than 8 mm, or less than 7 mm, or less than 6 mm, or less than 5 mm, or less than 4 mm. For example, the overlap of the skirt in the axial direction can be about 4-6 mm.
[0061] At least one skirt section (optionally each skirt section) may extend at least 1 mm away from the overlapping area in a non-overlapping axial distance. The non-overlapping distance of the skirt section or each skirt section may be, for example, at least 2 mm, or at least 3 mm, or at least 4 mm, or at least 5 mm, or at least 6 mm, or at least 7 mm, or at least 8 mm, or at least 9 mm, or at least 10 mm.
[0062] In some embodiments, the inflow edge or opening of the support member may have a zigzag shape defined by a mesh structure of at least one row of units. The zigzag shape may define an alternating sequence of free vertices (e.g., at the inflow end or defining the inflow end) and connecting vertices (e.g., connected to a mesh structure extending from the inflow end to the outflow end). In some embodiments, the inner skirt element may extend only to the connecting vertices. The outer skirt may overlap with the inner skirt and extend further than the inner skirt, reaching a level corresponding to at least some of the free vertices.
[0063] In some embodiments, the inner skirt element may extend toward the inflow end of the support structure. The outer skirt may only partially overlap the inner skirt while remaining spaced apart from the uppermost edge of the inner skirt. The outer skirt may extend toward (or optionally extend to) the inflow end of the support structure. The outer skirt may optionally not overlap any portion of the leaflet (e.g., directly or indirectly through the support member).
[0064] The inner and / or outer skirts can be made of any suitable material, such as pericardial tissue (e.g., thin porcine pericardium), PET, Dacron, etc. The inner and outer skirts may optionally be made of the same material.
[0065] Another object of the present invention is to provide a delivery system for delivering the artificial heart valve of the present invention. The delivery system includes a flexible tubular catheter comprising a proximal (or portion) and a distal (or portion) with a connecting device (e.g., a stent retainer). The delivery device also includes the artificial heart valve as described above. The delivery device is connected to the connecting device such that the device is adapted for placement in the ventricle or the portion of the device facing the ventricle is oriented toward the distal end of the catheter, while the portion of the device adapted for placement in the aorta is oriented toward the proximal end. Regarding the delivery device, the term "distal" refers to the operator remote from the delivery device, while the term "proximal" refers to the operator facing the delivery device.
[0066] However, regarding artificial heart valves, the term "distal" refers to the portion of the valve that is far from the aortic ventricle and therefore far from the inflow portion, while the term "proximal" refers to the portion of the valve that is towards the aortic ventricle and therefore towards the inflow portion of the stent structure.
[0067] The proximal end of the tubular catheter preferably includes a handle member for the operator. The distal end of the tubular catheter includes a connection device (e.g., a stent retainer) for releasable connection to the artificial heart valve according to the invention. The connection device can be of any suitable type. Preferably, the connection device is configured as a pin or other protrusion that mates with a corresponding attachment element (e.g., a hook and / or eyelet) on the artificial heart valve. As the stent component of the replacement device expands, the attachment element is released from the pin, thereby disengaging the device from the tubular catheter.
[0068] The orientation of the artificial heart valve on the tubular catheter allows for insertion along the patient's artery, preferably along the femoral or subclavian artery. Arterial insertion is beneficial for some patients because this procedure is less invasive than surgical intervention. The tubular catheter can also be configured for transapical insertion if desired.
[0069] According to another aspect of the invention, a method for replacing a heart valve is provided. The delivery device, as described above, is inserted in a compressed state into the location of the heart valve to be replaced. A stent structure is then expanded. The delivery device may optionally be inserted along an artery via a flexible tubular catheter, preferably along the femoral or subclavian artery. Alternatively, the delivery device may be inserted into the ventricle via the apex of the heart.
[0070] Another object of the present invention is to provide a method for manufacturing an artificial heart valve that reduces in size upon radial compression, a method that is rapid and easy to implement.
[0071] In some embodiments, in the first step of the method for producing an artificial heart valve according to the invention, one or more tubular skirt elements, preferably made of pericardial tissue, are provided. The term "tubular" must be understood to also include the skirt, which is generally shaped like a cylinder or a truncated cone. It also includes skirts having an elliptical cross-section, a radius varying along the axis, etc. The tubular skirt is preferably made of porcine pericardial tissue.
[0072] In the next step, at least two leaflets, preferably also made of pericardial tissue, are arranged adjacent to each other around the tubular skirt element. The leaflets are thus chosen to be sized such that, once arranged adjacent to each other, they span the entire circumference of the tubular skirt element. Therefore, the lateral edges of the leaflets contact at least in their upper free edge regions.
[0073] The leaflet can be cut from the pericardial tissue. The leaflet includes a free edge, which may optionally be curved. The curvature may be convex. In another embodiment, the curvature may be concave. The dimensions of the leaflet and the curvature of the free edge are thus selected to allow the free edges to seal against each other (e.g., engage) when the stent components are in a functional state. The leaflet also includes two side edges that taper towards the lower edge of the leaflet. The lower edge is shorter than the free edge. Preferably, the lower edge is also curved, more preferably having a convex curvature. The term "convex" is understood to define the curvature of the leaflet edge relative to the leaflet surface. Thus, the convexly curved edge protrudes from the leaflet.
[0074] At least one, preferably at least two, more preferably at least three leaflets preferably additionally include at least two tabs, with one tab thus arranged on each side edge of each leaflet, most preferably in the region of the free edge. Alternatively, at least two leaflets may include more tabs, for example, two tabs on each side edge of each leaflet.
[0075] Then, preferably, the tab is directly attached to the support structure, or more preferably, to an attachment device provided on the support connecting post, and then the tab is sewn to the connecting post. Excess material from the tab can then be removed.
[0076] As described above, the leaflet and skirt elements of an artificial heart valve need to be specifically adapted to the stent structure to which they will adhere. This is necessary to allow for the safe and reliable function of the artificial heart valve. For example, based on the overall configuration of the leaflet and / or skirt design, further minor dimensional variations can be indicated to find the optimal fit with the stent structure, optimize the opening / closing behavior of the artificial valve, thereby optimizing the relative hemodynamic performance of the valve, and ultimately optimizing the fatigue resistance of the stent and leaflets.
[0077] With this in mind, according to the present invention and as follows Figure 23A and 23B and Figure 24 The support structure shown is particularly characterized by:
[0078] - The conical and convex inlet portions allow for stable anchoring of the artificial heart valve in the annulus, while reducing any AV node stimulation through the specific distribution of radial forces in the inlet portions of the stent structure; thus, the radial force (COF, RRF) and compressibility of the stent structure are adapted to different functional requirements along the entire length of the stent. - The cylindrical and straight outflow section avoids any unwanted contact between the outflow section and the surrounding tissue; - A conical transition zone between the inflow and outflow portions, which has a suitably large inlet leading to the coronary artery, for example, for possible coronary intervention; - The inflow portion, transition zone and outflow portion are all configured to ensure the consistency of the prosthesis's scaffold structure with the surrounding anatomy at the implantation site; - The sheath can be repositioned / reinstalled at least three times without any significant loss of radial force of the support structure or any bending event; - The fineness of the inflow structure is increased (e.g., 12, 15, or 19 units) to achieve better adaptation between the scaffold structure and the annulus at the implantation site; - The fineness of the outflow structure is reduced (e.g., 3, 6, or 9 units) to allow more space for coronary artery access; - The support has well-adjustable stiffness throughout its length; - The overall length of the stent structure is shortened to reduce angular misalignment within the aorta.
[0079] Therefore, the inventors provide an artificial heart valve comprising a valve assembly (leaflet and skirt) that is well-suited to the stent structure described herein.
[0080] In one embodiment of the invention, the inner and outer skirts are made of the same material, which is pig pericardium.
[0081] In one embodiment of the invention, the inner and outer skirt materials can be made of different materials, such as esophagus and polymer.
[0082] In one embodiment of the invention, the suture material for the leaflet / skirt tissue component is selected from PTFE or UHMWPE. In one embodiment of the invention, PTFE is used for the valve subassembly, and UHMWPE is used for suturing the valve assembly to the stent structure.
[0083] The artificial heart valve of the present invention is provided for replacing a subject’s deficient natural aortic heart valve by minimally invasive delivery via the femoral artery through a suitable catheter, without prior surgical removal of the damaged natural aortic valve.
[0084] The artificial heart valve of the present invention includes a self-expanding stent structure, such as a nitinol stent, optionally including one or more distal connector elements, an inner skirt element, and two or more leaflets, preferably in a tri-leaflet configuration, all of which are sutured to the stent structure, and an outer skirt element extending from the proximal region of the stent, i.e., the inflow portion of the stent, to the lowest point of the prosthesis abdomen, which is also sutured to the stent structure together with the inner skirt element.
[0085] The most relevant technical features of the artificial heart valve according to the present invention can be summarized as follows: the artificial heart valve can be applied to aortic diameters ranging from 20 to 30 mm, but is not limited thereto. The prosthesis includes an inner skirt element and an outer skirt element to prevent leakage around the prosthetic valve. One, two, or more leaflets of the prosthesis follow the concept of a super-annular valve. According to the configuration of the stent structure associated with the valve assembly of the present invention described herein, the entire artificial heart valve is fully repositionable and re-insertable at least three times.
[0086] The valve leaflets of the present invention are designed to have dimensions with high engagement, low stress, low gradient and high effective orifice area (EOA).
[0087] The suture pattern according to the invention is used to securely assemble tissue components (e.g., leaflets and inner skirt elements) together and allows for smoother load transfer between the scaffold structure and the tissue components (leaflets and skirt) to increase the durability of the artificial heart valve.
[0088] Specifically, the outer skirt element of the present invention is configured to increase fluid resistance to diastolic return of the heart and fill potential gaps created by the presence of any geometric irregularities in the ring (e.g., due to localized calcification). Furthermore, the outer skirt element of the present invention is configured to ensure that interaction with the delivery system, i.e., the loading / release and reloading sheath phases, does not impair the short- and long-term function and safety of the artificial heart valve, and does not impair or create additional obstruction to coronary perfusion and post-implantation access.
[0089] While certain aspects of the invention have been defined above, any novel features or ideas shown in the description and / or drawings herein are claimed, whether or not such features or ideas are emphasized.
[0090] Medical implants can be used to treat stenosis (narrowing) and / or valvular insufficiency of heart valves and can replace a patient's natural heart valves. Each of at least two leaflets of the medical implant is constructed of natural tissue or synthetic material and has a first open position for opening the patient's ventricle and a second closed position for closing the patient's ventricle. The at least two leaflets are capable of switching between their first and second positions in response to blood flow through the patient's heart. Furthermore, the medical implant may include a compressible and expandable stent structure, allowing delivery of the medical implant to the implantation site using a catheter.
[0091] The above description of "heart valve stenosis and / or heart valve insufficiency" can include functional defects in one or more of a patient's natural heart valves, which may be hereditary or acquired. This type of heart defect can affect each of the four heart valves, although the aortic and mitral valves are more frequently affected than the right side of the heart (pulmonary and tricuspid valves). The functional defect can result in stenosis, inability to close (insufficiency), or both (combined defects). This disclosure relates to artificial heart valves and catheter-delivered internal prostheses comprising an artificial heart valve and an expandable stent capable of being implanted transcavitarily into a patient and radially expanded upon introduction via catheter delivery for the treatment of such heart valve defects. In cases of stenosis, the natural heart valve cannot open properly, and thus valve insufficiency represents the opposite effect, exhibiting inadequate closure characteristics. Medical conditions such as hypertension, inflammation, and infection processes can lead to this heart valve dysfunction. In either case, in most cases, autologous valves must be treated surgically. In this regard, treatment can include repairing the diseased heart valve and preserving the patient's own valve, or replacing the valve with a mechanical or biological substitute (also known as a prosthetic heart valve). However, especially for aortic heart valves, heart valve replacement is often necessary.
[0092] Further improvements are desired in medical implants to reduce PVL (Potential Volume Limit), while taking into account the compressibility of the implant under compression. Furthermore, a simple and cost-effective manufacturing method for such a medical implant will be described.
[0093] Specifically, medical implants used for delivery to the implantation site via catheter include:
[0094] - An implantable component defining a flow channel for guiding and / or controlling fluid flow, the flow channel having an inlet end and an outlet end, wherein the medical implantable component includes a scaffold structure. - The support structure has a compressible state and can expand to a functional state. The support structure includes a first support structure end, a second support structure end, multiple pillars, and a longitudinal axis. The support structure comprises multiple units, each complete unit comprising two zigzag structures formed by the multiple pillars, the vertices of which are connected together. Each zigzag structure extends relative to the longitudinal axis around the entire circumference of the support structure. - An outer skirt that extends at least partially outside the support structure, wherein the outer skirt is secured to the support structure using stitches at least in the sealing portion and the folding portion. - In the sealing section, the outer skirt is sewn along the entire circumference of the support structure to each of at least two directly adjacent zigzag structures, and - In the folding portion, the outer skirt is sewn to at least a portion of a pillar of a zigzag structure surrounding the entire circumference of the support structure, such that the outer skirt forms at least one fold, which, when the medical implant is placed at the implantation site, produces a diameter-enlarging structure or a fluid-redirecting structure through the interaction of fluid flow between the medical implant components and the anatomical structure.
[0095] The medical implant component further surrounds the flow channel and provides support and anchorage for the medical implant at the implantation site, particularly through its scaffold structure. The medical implant component may also include a valve assembly, wherein the valve assembly may include at least two or three leaflets. The valve assembly may also include an inner skirt to which at least two leaflets are secured. The valve assembly may extend at least partially within the scaffold structure. The inner skirt may extend to the inflow end of the flow channel (or scaffold structure), or the inner skirt may be located at a predetermined distance from the inflow end of the flow channel (or scaffold structure).
[0096] As described above, the stent structure has a compressible state and is expandable into a functional state, wherein the outer diameter of the stent structure is smaller in the compressible state. The stent structure may be tubular. Furthermore, the stent structure includes multiple units defining the contour and longitudinal axis of the medical implant component, wherein each complete unit includes two zigzag structures formed by multiple struts. Each half-unit may include only one such zigzag structure. The vertices of the zigzag structures are connected together, wherein each zigzag structure extends around the entire circumference of the stent structure relative to the longitudinal axis. The stent structure may be self-expanding or balloon-expanding. The construction of a stent structure having units including zigzag strut structures allows the medical implant to adapt to the patient's anatomy at the implantation site to secure other components of the component, such as valve assemblies, and to secure the outer skirt. Furthermore, the stent structure absorbs radial and longitudinal forces acting on the medical implant. The stent structure may also provide a uniform stress distribution along its multiple units. In the functional state, the inner diameter of the stent structure at the second stent structure end may be larger than the inner diameter at the first stent structure end. At the first support structure end, the diameter of the support structure can be larger than the diameter along the longitudinal axis of the support structure towards the second support structure end. In this intermediate support structure section, the support structure can form the abdomen and the lowest point of the abdomen.
[0097] According to the invention, PVL is reduced by an outer skirt that extends at least partially to the exterior of the stent structure and / or component. In one embodiment, the outer skirt is completely housed on the exterior of the stent structure, i.e., its outer surface. The outer skirt is secured to the stent structure using sutures. The attachment area consists at least of a sealing portion and a fold-generating portion of the outer skirt. The sealing portion provides a stable (firm) and sealed attachment of the outer skirt to the stent structure. This is achieved by suturing the outer skirt along the entire circumference of the stent structure to each of at least two directly adjacent struts of a zigzag structure. The sealing portion further supports the retractability of the medical implant, particularly with respect to its outer skirt. In the fold-generating portion, the outer skirt is suturing around the entire circumference of the stent structure to at least a portion of a strut of a zigzag structure with a specific suture pattern. The sutures and the characteristics of the outer skirt in both portions are further tailored such that the outer skirt forms at least one fold that, when the medical implant is placed at the implantation site, creates a diameter-enlarging structure or a fluid-redirecting structure through fluid flow interaction between the medical implant component and the anatomical structure. The folding portion provides at least one fold within the outer skirt, which develops in a predictable manner during compression (i.e., curling). In one embodiment, in the functional state, the outer fold protrudes toward the anatomical structure, thereby increasing contact with the anatomical structure. In another embodiment, fluid is redirected from a longitudinal direction to a radial direction by channels formed by the folds.
[0098] In one embodiment, the folded portion is further away from the end of the second support structure than the sealing portion. Therefore, the folded structure interacts directly with the reverse-flowing fluid to prevent PVL (Potentially Volatile Fluid).
[0099] In one embodiment, the folding portion is further away from the second support structure end than the sealing portion, and the outer skirt is sewn to the support structure at the folding portion, extending along the entire circumference of the support structure to each second strut. In this embodiment, the outer skirt may include a through-hole, such as a slit or hole with a circular or semi-circular cross-section, at the first folding end, which is further away from the first support structure end than the second folding end. In this configuration, the outer skirt forms a slightly curved fold or pleat in the form of a "bagpipe" (curved to a direction perpendicular to the longitudinal direction, but with a through-hole or slit). After implantation at the implantation site, reverse blood flow enters the pleat at the folding portion of the outer skirt, flows within the fold, and exits the fold at the opposite end through a side opening. In the "bagpipe" skirt configuration, blood is not trapped but redirected. Blood is guided into the fold at the folding portion and radially redirected through the side opening, thereby reducing PVL. For this embodiment, the circumferential length of the outer skirt can be determined such that it is equal to the support structure at the abdominal level not far from the first support structure end and at the inflow level. The height of the skirt can be designed to be equal to the height of the support structure between the end of the first support structure and the lowest point of the abdominal part of the support structure.
[0100] In another embodiment, the fold-generating portion is further away from the second support structure end than the sealing portion. The outer skirt folds outside the sealing portion and is sewn into the support structure within the fold-generating portion, stitching to each strut along the entire circumference of the support structure. In this embodiment, the outer skirt folds along the entire circumference at the first support structure end such that it overlaps with the sealing portion. In the region of the sealing portion, the outer skirt is a double-layered structure. The folded outer skirt portion is then sewn into the end of the support structure, which shows the outflow direction forming the fold-generating portion. When the medical implant is finally rolled down to its compressed state, the outer skirt exhibits a characteristic cow-slippery shape. This constructs the outer skirt as a reinforced, non-circular, gasket-like structure for sealing the space between the medical implant and the anatomical structure of the implantation site. In this embodiment, the circumferential length of the outer skirt may be dimensioned such that it is equal to the level of the support structure at the abdominal level, if a lowest point of the abdomen exists, and at the level of the first support structure end. The height of the outer skirt can be longer than the height of the support structure between the lowest point of the abdomen and the end of the first support structure, because in this embodiment, the outer skirt should fold along the longitudinal axis of the support structure during the assembly of the medical implant. This creates a washer-like structure (formed due to the stacking of at least two layers of the outer skirt). Furthermore, by constraining the outer layer at specific points sutured to the support structure, the outer skirt in this embodiment can be forced with no / negligible axial relaxation to drive folding, resulting in contraction, and when the medical implant is finally compressed, the support shortens only in the circumferential direction, resulting in a cow-slippery shape.
[0101] In the above embodiments, the sealing portion may be provided by at least two directly adjacent zigzag structures closest to the absolute first support structure end, or one of them may at least partially form the absolute first support structure end.
[0102] In another embodiment, the folding portion is further away from the first support structure end than the sealing portion, and the outer skirt is sutured to the support structure in the folding portion, and sutured to each second strut along the entire circumference of the support structure. By selectively restricting the sutures in a zigzag structure at the first support structure end, the resulting unrestricted outer skirt surface is folded when the prosthesis is compressed, for example by curling. In this configuration, the skirt presents a shape resembling a "Hawaiian skirt" (here referring to a pleated skirt). In the Hawaiian skirt structure, no blood is trapped. The "Hawaiian skirt" is based on the concept of an inner wall skirt, wherein the circumferential length of the outer skirt can be dimensioned such that it is equal to the level of the support structure at the abdominal level and at the level furthest from the first support structure end. The height of the outer skirt can be dimensioned such that it is equal to the height of the support structure between the level furthest from the first support structure end and the lowest point of the abdomen. In this embodiment, the folding portion may be provided by a zigzag structure that is closest to (closest to) the absolute first support structure end or at least partially forms the absolute first support structure end. The proposed concept actively seeks strategies to reduce PVL (Potential Velocity) while minimizing the impact on the overall curl profile of the medical implant. The outer skirt (and associated suture pattern) of this invention is designed to increase fluid resistance to backflow during diastole and to fill potential gaps created by any geometric irregularities present in the ring, such as due to localized calcification. Due to the specific suture pattern, the outer skirt of this embodiment is configured to ensure predictable foldability. Therefore, it allows for improved sealing performance without affecting the curl profile.
[0103] In one embodiment, the inner skirt, outer skirt, and leaflet may be composed of porcine, bovine, equine, or other mammalian tissue, such as pericardial tissue, and sutured, welded, molded, or glued together to effectively distribute force along the leaflet onto the scaffold structure. In a particularly preferred embodiment, the inner skirt may comprise three mammalian tissue portions joined together along adjacent edges, allowing the tissue to be easily folded into a contracted delivery shape without clumping. Alternatively, the inner and outer skirts of the valve assembly may comprise synthetic or polymeric materials, such as Dacron, expanded polytetrafluoroethylene (“ePTFE”), or other suitable synthetic graft materials. The valve assembly leaflet may be composed of porcine, bovine, equine, or other mammalian tissue, such as pericardial tissue, and sutured, welded, molded, or glued to the skirt to effectively distribute force along the leaflet onto the scaffold structure. Using synthetic or polymeric materials for the inner skirt, which is attached to mammalian tissue leaflets, can provide significant advantages. In particular, synthetic materials can provide the same structural properties as mammalian tissue, but with reduced thickness, allowing the valve assembly to be folded into a smaller delivery profile. Alternatively, the leaflets may also comprise synthetic or polymeric materials. According to embodiments of the invention, the stent structure comprises multiple stages, including a proximal tapered inflow portion, a constricting region, and an open distal outflow portion. Each of the inflow and outflow portions is deformable into a non-circular cross-section to conform to the patient's anatomy, while the constricting region is configured to maintain a circular cross-section, thus preserving the normal function of the valve assembly.
[0104] The scaffold structure comprises multiple units forming a unit pattern that can vary along the length of the scaffold structure to provide high anchorage and alignment of the valve prosthesis. The unit pattern is further selected to provide a uniform diameter, wherein the commissural joints of the leaflets are attached to the scaffold structure, while allowing the inflow and outflow areas to expand to conform to the patient's anatomy. In this way, optimal function of the valve assembly can be achieved even if the scaffold structure can be deployed within anatomy with a range of sizes. Furthermore, the scaffold structure resists deformation caused by cardiac motion and allows the functional portions of the valve assembly to be positioned on the superannulus of the natural valve, while a portion of the artificial valve extends into the natural valve annulus. The scaffold structure can be constructed of biocompatible metallic materials. The scaffold structure can include or be constructed of shape memory materials / alloys, such as nitinol.
[0105] In one embodiment, a suture extends over one zigzag structure or over at least two zigzag structures. The suture is a structure comprising multiple stitches performed one after another using at least one suture as the suture material. The suture can be formed from a single continuous thread or from a thread cut into multiple individual sections, each section forming, for example, at least one knot. According to this embodiment, a suture can extend over at least two directly adjacent (longitudinal) zigzag structures. Due to the suture, the valve assembly and outer skirt are reliably attached to the stent structure without adding too much volume in the event of stent structure collapse. For example, the suture material can be a braided multifilament polyester material. These sutures can have any suitable diameter, typically about 0.07 mm. However, to increase the connection strength between the valve assembly or outer skirt and the stent structure, the diameter of the multifilament suture can be increased, for example, to 0.2 mm. Thus, the basic bond between the valve portion of the valve assembly, comprising at least two leaflets, and the struts of the stent structure can exhibit additional stability. On the other hand, the remaining sutures should be kept as thin as possible to allow the medical implant to shrink to a small diameter. The combination can be achieved using common continuous stitch patterns. These patterns can be lockstitch, blanket stitch, and Armenian stitch, respectively. Of course, any other suitable stitch pattern (i.e., overlock stitch, slip stitch, or topstitch) is also possible.
[0106] In one embodiment, if both sutures extend over at least two zigzag structures, the second suture overlaps with the first suture. Regarding sutures, overlap means that the second suture intersects the first suture at certain points, such as at the apex of the corresponding zigzag structure. By intersecting the first suture, the second suture sutures downwards from the first suture in the intersection region, thereby more reliably securing the valve assembly and / or outer skirt to the stent structure.
[0107] In one embodiment, in the folding section, the stitching material is wrapped around the supports without passing through the outer skirt, where the stitching material does not secure the outer skirt to the support structure. In this section, the stitches are guided along the structure of the support structure by the respective supports so that stitching continues at the ends of the supports where the outer skirt is not secured. This reduces production time.
[0108] The outer skirt can be a single piece or can be composed of multiple pieces, for example, sewn together or welded together. The outer skirt can be formed very much like a rectangular or slightly curved rectangle of textile / fabric. In one embodiment, at its longest opposing edges, the outer skirt may include a serrated or rounded or straight first edge and / or a serrated or rounded or straight second edge. Using different types of edges, the outer skirt may be best suited to the support structure.
[0109] The outer skirt can be manufactured using a 3D molding process. This process allows for the creation of seamless, three-dimensionally shaped outer skirts. The 3D-shaped outer skirt can have any desired shape and / or its surface can have any desired structure. The 3D-shaped outer skirt can have an external shape capable of reliably sealing the medical implant against the surrounding anatomical structures at the implantation site. Sealing can be achieved intravalvular, subannular, or supravalvular, or combinations thereof. The outer skirt can be particularly well-suited for stent structures (e.g., cylindrical). Structures on the outer skirt surface can have any solid graphic shape. The skirt at least partially covers the outer side of the stent structure, or the outer skirt can have a three-dimensional structure.
[0110] A variety of possible 3D structures can be used to seal medical implants against the surrounding anatomical structures at the implantation site. Preferably, the three-dimensional shape structure on the outer skirt surface can be at least one of protrusions and / or depressions (valves): - Bubbles, spheres, spherical bodies, ellipsoids, or shapes that are typically obtained by cutting these solids with a plane. - Folded or pleated - Polyhedron, - (Slender) channels, turbine-like structures, folds - recesses, recesses, grooves, Or a combination of them.
[0111] The three-dimensional shape structure on the surface of the outer skirt can be the inverse form of the anatomical structure surrounding the medical implant at the implantation site.
[0112] The skirt or outer skirt that at least partially covers the outside of the support structure may have a corrugated tubular structure or may be a pleated skirt (with folds / pleats).
[0113] The structure on the surface of the outer skirt can have alternations of peaks and valleys (e.g., at least 30%).
[0114] During implantation, the protrusion can protrude into the surrounding anatomical structures.
[0115] A depression can protrude from the surrounding anatomical structures at the implantation site.
[0116] The external structure may have at least one suction cup that can seal the medical implant onto the surrounding anatomical structures at the implantation site.
[0117] The outer skirt may have at least one notch, recess, gap, or channel between the natural aortic valve annulus and the artificial valve (to improve sealing and reduce PVL leakage after unfolding, while maintaining controlled load distribution and controllable folding during roll-up).
[0118] Furthermore, the 3D structure means covering as much of the outer skirt surface as possible, thereby also covering most of the sealing hotspots (inner valve, under the annulus, and above the valve). Additionally, the presence of the 3D structure increases the hydraulic resistance of the medical implant to blood return.
[0119] This 3D-shaped outer skirt can help significantly limit or prevent any leakage around the valve by:
[0120] (a) Increase the surface area of the outer skirt in the sealed area. (b) Increase the contact surface between the skirt and the anatomical sites surrounding the implant; for example, within the annular region (but implantation above and below the annulus is also possible); and (c) Increases the fluid resistance of medical implants to blood return, especially in the presence of calcified nodules on the aortic valve.
[0121] Regardless of how the prosthesis works (i.e., intraluminal, supraluminal, short stent, long stent), the 3D-shaped outer skirt can be applied to any TAVR implant. Therefore, the 3D-shaped outer skirt is designed to cover most of the diverse patient populations.
[0122] In one embodiment, the outer skirt includes multiple laser markers within its suture area that partially penetrate the material of the outer skirt along its thickness. Each laser marker can be used for suturing, where the reduced material thickness facilitates the suturing / sewing process without compromising the structural integrity of the outer skirt material (e.g., biological tissue). A laser marking method, rather than perforation / drilling (mechanically or with a laser), has been developed where the point to be perforated is identified by locally sculpting the surface of the outer skirt material. Unlike holes, laser marking preserves most of the tissue's structure (e.g., biological structures), thus minimizing disruption to the material's structural integrity. It can be seen that the laser markers only partially penetrate the material thickness. By appropriately adjusting the laser power and speed, laser markers of sufficient depth can be identified. These markers can be large enough that the operator can see them on the surface of the outer skirt during suturing, while being small enough to minimize impact on the overall structure of the tissue. This can be achieved by appropriately adjusting the speed and power of the laser used to cut the material. This invention improves the assembly process by minimizing manufacturing inaccuracies and errors: the use of laser marking, by assisting each stitch with optimized, minimal indications, is an effective and appropriate way to ensure design consistency, quality, and increased yield. If the valve assembly consists of multiple components, laser marking on the leaflet or inner skirt surface can also be used to facilitate the suturing of these elements.
[0123] Furthermore, regarding the use of lasers to create partially penetrating laser marks (L-ASP) mentioned above, small circles with a diameter of, for example, less than 0.06 mm are used in CAD software. The CAD file can then be converted into a cutting file. For the specific laser currently in use (general purpose), the first difficulty in the manufacturability of laser marks is fully importing the small circles into the laser cutting machine software, which forms the laser marks after laser operation. On the one hand, the circles should be small so that the laser marks are not too large. On the other hand, very small circles will lead to losses when importing the cutting file. There is a trade-off between the number of circles and their diameters. The more circles on the cutting file, the larger the diameter should be to ensure complete import into the laser cutting machine software. The diameter of the circles used for laser marks can be between 0.01 mm and 0.06 mm. Considering the large number of circles, their diameters may be too small. This could lead to file loss after import. By repeatedly increasing the diameter of the circles with each import, the minimum diameter required for complete import of the circles can be determined. Laser marks are a powerful sewing tool that can be used in conjunction with different topological distributions (markers) on the parts to be sewn. Examples of these distributions are bi-pattern and alternating patterns, where in the bi-pattern topology the markers are separated by a distance equal to the spacing length, and in the alternating pattern topology the laser markers are separated by a distance equal to twice the spacing length. In the latter case, by using opposing layers with laser markers shifted relative to the first layer, each layer includes laser markers in an alternating manner within the spacing length.
[0124] In one embodiment, the sutures of the outer skirt and / or the sutures of the valve assembly of the medical implant component are covered by a protective stitch structure, wherein the valve assembly extends at least partially within the stent structure. This means there are two overlapping sutures: a first suture as described above and a second protective stitch structure sutured to and thus accommodated on the first suture. This protective stitch structure can be used for sutures securing the outer skirt to the stent structure, or for sutures securing the valve assembly to the stent structure, wherein the valve assembly may include at least two leaflets and, if applicable, an inner skirt. The proposed suture pattern helps prevent thinning / damage of the sutures on the stent structure and ensures structural resilience and enhances the structural durability of the implant, particularly at critical points or areas. The same thread material as the first suture can be used for the protective suture structure. In one embodiment, the sutures of the outer skirt and / or the sutures of the valve assembly are provided in one direction along a longitudinal axis, and the protective stitch structure is provided in the opposite direction relative to that direction. Furthermore, in one embodiment, the first suture is at least partially formed by Armenian stitches, and / or the protective suture structure is at least partially formed by whip stitches. This is because the higher the radial force and reduced posterior deflection of the stent structure, the more likely it is that the sutures on the stent structure struts will wear down (so-called suture breakage). Repeated re-insertion of the medical implant can also cause suture thinning / damage in certain critical areas. Additionally, the valve assembly or outer skirt may have minor movements relative to the stent structure, which can also lead to wear. Another advantage is that the protective stitch structure protects the first suture during contraction (e.g., curling) and provides some cushioning for the main suture.
[0125] In another embodiment, the suture or protective stitch structure includes two knots at the nutcracker eye at the end of the first support structure. Using this structure, the outer skirt can be secured to the support structure, for example, at the apex of the first support structure end, where the supports can converge to form a so-called nutcracker structure with a nutcracker shape. The nutcracker eye is a through-hole at the center of the nutcracker structure. In this structure, when stitching twice, the thread forms a loop as it passes around the support at the nutcracker eye, and a knot is formed by crossing below the loop.
[0126] In another embodiment, the suture or stitch structure extends through three openings within the outer skirt and / or valve assembly at the apex of the stent structure, and wherein the suture or stitch structure forms a clover knot. This type of knot is obtained as a variation of the standard whip stitch. Specifically, the suture passes through the previous “whip loop” and crosses around the strut once (or several times consecutively), rather than forming a continuous spiral of suture loops around the strut of the stent structure. The tissue will be punctured only on one side of the stent strut, while on the opposite side, the suture will simply wrap around the stent strut, thus clamping the tissue profile in the middle. This type of knot is inspired by the so-called “clover knot,” which is widely used for many non-medical purposes (e.g., climbing). It is a self-tightening system when one end is pulled (e.g., during the coiling or release of the implant), thereby inhibiting movement of the suture pattern along the stent structure. This property makes this type of knot suitable for challenging sites in implant (BE or SE stent) assembly, such as the apex or end of the unit pattern, where the likelihood of tissue component movement is high (especially during vigorous interaction with the delivery system). The pores within the outer skirt or valve assembly enhance the force / strain distribution. Regarding the two special knot structures discussed above, an advantage is that the suturing process is streamlined in terms of implant fabrication and training time, which increases pattern repeatability.
[0127] As described above, medical implants may in particular be valve prostheses, and the implantation site is within the patient's heart, adjacent to or within a natural heart valve, wherein the medical implant component includes a stent structure and / or a valve assembly comprising at least two leaflets, wherein the valve assembly is attached to the stent structure and extends at least partially within the stent structure.
[0128] Medical implants can be implanted using minimally invasive, catheter-based, or percutaneous implantation techniques, but this also includes implantation using open surgical techniques.
[0129] Specifically, the above objective is achieved by a method for manufacturing an implant for delivery via a catheter to the implantation site, the method comprising the following steps:
[0130] - An implantable component is provided that defines a flow channel for guiding and / or controlling fluid flow, the flow channel having an inlet end and an outlet end, wherein the medical implantable component includes a scaffold structure having a compressible state and a functional state, wherein the scaffold structure includes a first scaffold structure end located at the inlet end of the flow channel, a second scaffold structure end, and a plurality of units defining the outline and longitudinal axis of the medical implantable component, wherein each complete unit comprises two zigzag structures formed by a plurality of struts, wherein the vertices of the zigzag structures are connected together, and wherein each zigzag structure extends about the entire circumference of the scaffold structure relative to the longitudinal axis. - Provides an outer skirt. - At least at the sealing and folding portions, the outer skirt is secured to the support structure using stitches, such that it extends at least partially to the outside of the support structure, and - This ensures that in the sealing section, the outer skirt is fixed along the entire circumference of the support structure, preferably sewn to each of at least two directly adjacent zigzag structures, and - This results in the outer skirt being fixed around the entire circumference of the support structure at the folding portion, preferably sewn to at least a portion of a zigzag structure pillar, and causing the outer skirt to form a fold that, when the medical implant is placed at the implantation site, produces a diameter-enlarging structure or a fluid-redirecting structure through interaction with fluid flow.
[0131] The methods described above are simple and cost-effective for manufacturing implants with the aforementioned advantages. The manufacturing method may include the features of the medical implant described above. Specifically, the manufacturing method can be used to manufacture a valve prosthesis, wherein the medical implant component includes a scaffold structure and / or a valve assembly comprising at least two leaflets, wherein the valve assembly is fixed to the scaffold structure and extends at least partially within the scaffold structure. The valve assembly may include an inner skirt, wherein at least two leaflets are attached (e.g., sutured) to the inner skirt. In one embodiment, suturing of the outer skirt may be provided such that the outer skirt is at least partially sutured to the inner skirt.
[0132] The present invention also includes embodiments represented by the examples numbered below.
[0133] 1. A medical implant for delivery via catheter to an implantation site, comprising:
[0134] - An implantable component defining a flow channel for guiding and / or controlling fluid flow, the flow channel having an inlet end and an outlet end, wherein the medical implantable component includes a scaffold structure and an outer skirt. - The support structure has a compressible state and can expand to a functional state, and the support structure includes a first support structure end, a second support structure end opposite to the first support structure end, multiple units, and a longitudinal axis. - Each complete unit comprises two zigzag structures formed by multiple pillars, wherein the vertices of the zigzag structures are joined together, and each zigzag structure extends around the entire circumference of the support structure relative to the longitudinal axis. - An outer skirt that extends at least partially outside the support structure, wherein the outer skirt is secured to the support structure and / or the inner skirt at least at the sealing portion and the folding portion. - In the sealing section, the outer skirt is fixed to each of at least two directly adjacent zigzag structures along the entire circumference of the support structure and / or fixed to the inner skirt, and - In the folding portion, the outer skirt is fixed to at least a portion of a zigzag structure pillar around the entire circumference of the support structure and / or fixed to the inner skirt, such that the outer skirt forms a fold that, when the medical implant is placed at the implantation site, produces a diameter-enlarging structure or a fluid-redirecting structure through fluid flow interaction between the medical implant components and anatomical structures.
[0135] 2. The medical implant according to Example 1, wherein the folded portion is located further away from the end of the second stent structure than the sealed portion.
[0136] 3. The medical implant according to Example 2, wherein the outer skirt is sutured to the scaffold structure at the folded portion and sutured to each second strut along the entire circumference of the scaffold structure.
[0137] 4. The medical implant according to Example 3, wherein the outer skirt includes a through hole at the first folded end, such as a slit or hole having a circular or semi-circular cross-section, and the first folded end is further away from the first support structure end than the second folded end.
[0138] 5. The medical implant according to Example 2, wherein the outer skirt is folded over the outside of the sealing portion and sutured to the scaffold structure at the folding portion to reach each strut along the entire circumference of the scaffold structure.
[0139] 6. The medical implant according to Example 1, wherein the fold-generating portion is located further away from the end of the first support structure than the sealing portion, and wherein the outer skirt is sutured to the support structure at the fold-generating portion, extending along the entire circumference of the support structure to each second strut.
[0140] 7. The medical implant according to any of the foregoing embodiments, wherein a suture extends over one zigzag structure or over at least two zigzag structures.
[0141] 8. The medical implant according to Example 7, wherein if both sutures extend over at least two zigzag structures, the second suture overlaps with the first suture.
[0142] 9. A medical implant according to any one of embodiments 3 to 4 and 6 to 8, wherein at the folded portion, suture material is wrapped around those pillars without passing through the outer skirt, and at the outer skirt, the suture material does not secure the outer skirt to the support structure.
[0143] 10. A medical implant according to any of the foregoing embodiments, wherein the outer skirt includes a serrated or rounded or straight first edge and / or a serrated or rounded or straight second edge.
[0144] 11. A medical implant for delivery via catheter to an implantation site, comprising:
[0145] - An implantable component defining a flow channel for guiding and / or controlling fluid flow, the flow channel having an inflow end and an outflow end, wherein the medical implantable component includes a scaffold structure and an outer skirt, as well as a valve assembly. - The support structure has a compressible state and can expand to a functional state, and the support structure includes a first support structure end, a second support structure end opposite to the first support structure end, multiple units, and a longitudinal axis. - An outer skirt that extends at least partially to the outside of the support structure, wherein the outer skirt is secured to the support structure with sutures in the stitching area.
[0146] 12. A medical implant according to any one of Examples 1 to 10, wherein the outer skirt, inner skirt and / or leaflet includes a plurality of laser markers in its suture area, the laser markers partially penetrating the material in which they are made along the thickness of the material, or wherein the outer skirt, inner skirt and / or leaflet includes a plurality of laser holes in its suture area, the laser holes completely penetrating the material in which they are made along the thickness of the material in which they are made.
[0147] 13. The medical implant according to Example 11 or 12, wherein the laser marking on the outer surface of the outer skirt is optically visible.
[0148] 14. A medical implant for delivery via catheter to an implantation site, comprising:
[0149] - An implantable component defining a flow channel for guiding and / or controlling fluid flow, the flow channel having an inflow end and an outflow end, wherein the medical implantable component includes a scaffold structure, an outer skirt, and a valve assembly. - The support structure has a compressible state and can expand to a functional state, and the support structure includes a first support structure end, a second support structure end opposite to the first support structure end, multiple units, and a longitudinal axis. - An outer skirt that extends at least partially to the outside of the support structure, wherein the outer skirt is secured to the support structure with stitching. - Wherein the sutures of the outer skirt and / or the sutures of the valve assembly of the medical implant component are covered by a protective stitch structure, wherein the valve assembly extends at least partially within the stent structure.
[0150] 15. A medical implant according to any one of embodiments 1 to 13, wherein the sutures of the outer skirt of the medical implant component and / or the sutures of the valve assembly are covered by a protective stitch structure, wherein the valve assembly extends at least partially within the stent structure.
[0151] 16. The medical implant according to Example 15, wherein the sutures of the outer skirt and / or the sutures of the valve assembly are provided in one direction along the longitudinal axis, and the protective stitch structure is provided in the same or opposite direction relative to one direction.
[0152] 17. The medical implant according to any one of the foregoing embodiments 1 to 16, wherein the suture is at least partially formed by Armenian stitches, and / or the protective suture structure is at least partially formed by whip-like stitches.
[0153] 18. A medical implant for delivery via catheter to an implantation site, comprising:
[0154] - An implantable component defining a flow channel for guiding and / or controlling fluid flow, the flow channel having an inlet end and an outlet end, wherein the medical implantable component includes a scaffold structure and an outer skirt. - The support structure has a compressible state and can expand to a functional state, and the support structure includes a first support structure end, a second support structure end opposite to the first support structure end, multiple units, and a longitudinal axis. - An outer skirt that extends at least partially to the outside of the support structure, wherein the outer skirt is secured to the support structure with sutures, wherein the sutures or stitches contain two knots at the nutcracker eye at the end of the first support structure.
[0155] 19. A medical implant according to any one of embodiments 1 to 17, wherein the suture structure or stitch structure includes two knots at the nutcracker eye of the first stent structure end.
[0156] 20. A medical implant according to any one of embodiments 1 to 19, wherein the suture structure or stitch structure extends through a hole in the outer skirt and / or valve assembly at the apex of the stent structure, and wherein the suture structure or stitch structure forms a clover knot.
[0157] 21. A medical implant according to any one of claims 1 to 20, wherein the medical implant is a heart valve prosthesis and the implantation site is located in the patient's heart adjacent to or within a natural heart valve, wherein the medical implant component includes a stent structure and / or a valve assembly comprising at least two leaflets, wherein the valve assembly is fixed to the stent structure and extends at least partially within the stent structure.
[0158] 22. A method for manufacturing an implant for delivery to an implantation site via a catheter, comprising the following steps:
[0159] - An implantable component is provided that defines a flow channel for guiding and / or controlling fluid flow, the flow channel having an inlet end and an outlet end, wherein the medical implantable component includes a support structure and an outer skirt, wherein the support structure has a compressible state and is expandable to a functional state, and wherein the support structure includes a first support structure end, a second support structure end opposite to the first support structure end, a plurality of units, and a longitudinal axis, wherein each complete unit comprises two zigzag structures formed by a plurality of struts, wherein the vertices of the zigzag structures are connected together, and wherein each zigzag structure extends about the entire circumference of the support structure relative to the longitudinal axis. - Provides an outer skirt. - At least at the sealing and folding portions, the outer skirt is secured to the support structure using stitches, such that it extends at least partially to the outside of the support structure, and - This ensures that in the sealing section, the outer skirt is sewn along the entire circumference of the support structure to each of at least two directly adjacent zigzag structures, and - This results in the outer skirt being sewn to at least a portion of a pillar of a zigzag structure around the entire circumference of the support structure at the fold-forming portion, and causing the outer skirt to form a fold that, when the medical implant is placed at the implantation site, produces a diameter-enlarging structure or a fluid-redirecting structure through interaction with fluid flow.
[0160] 23. The method according to embodiment 22, wherein the folded portion is located further away from the end of the second support structure than the sealing portion.
[0161] 24. The method according to embodiment 23, wherein the outer skirt is sewn to the support structure at the folded portion, along the entire circumference of the support structure to each second pillar.
[0162] 25. The method according to embodiment 24, wherein the outer skirt includes a through hole at the first folded end, such as a slit or hole having a circular or semi-circular cross-section, the first folded end being further away from the first support structure end than the second folded end.
[0163] 26. The method according to embodiment 23, wherein the outer skirt is folded outside the sealing portion and sewn to the support structure at the fold-forming portion, along the entire circumference of the support structure to each pillar.
[0164] 27. The method according to embodiment 22, wherein the fold-generating portion is located further away from the end of the first support structure than the sealing portion, and wherein the outer skirt is sewn to the support structure at the fold-generating portion, along the entire circumference of the support structure to each second pillar.
[0165] 28. The method according to any one of embodiments 22 to 27, wherein a suture line is sewn so that it extends over one zigzag structure or over at least two zigzag structures.
[0166] 29. The method according to embodiment 28, wherein a second suture is sutured after the first suture, such that if both sutures extend over at least two zigzag structures, the second suture overlaps with the first suture.
[0167] 30. The method according to any one of embodiments 24 to 25 and 27 to 29, wherein during stitching in the fold-forming portion, the stitching material wraps around those supports without passing through the outer skirt, at which point the stitching material does not secure the outer skirt to the support structure.
[0168] 31. The method according to any one of embodiments 22 to 30, wherein the provided outer skirt includes a first edge that is serrated or rounded or straight and / or a second edge that is serrated or rounded or straight.
[0169] 32. The method according to any one of embodiments 22 to 31, wherein a plurality of laser marks are generated in the stitching area of the outer skirt, the inner skirt and / or the leaflets, which partially penetrate the material of the outer skirt along the thickness of the outer skirt, or wherein a plurality of laser holes are generated in the stitching area of the outer skirt, the inner skirt and / or the leaflets, which completely penetrate the material of the outer skirt along the thickness of the outer skirt.
[0170] 33. The method according to embodiment 32, wherein the laser marking is optically visible on the outer surface of the outer skirt.
[0171] 34. The method according to any one of embodiments 22 to 33, wherein after suturing the sutures of the outer skirt and / or after suturing the sutures of the valve assembly of the medical implant component, a covering protective stitch structure is provided on the respective sutures, wherein the valve assembly extends at least partially within the stent structure.
[0172] 35. The medical implant according to Example 34, wherein the sutures of the outer skirt and / or the sutures of the valve assembly are provided in one direction along the longitudinal axis, and the protective stitch structure is provided in the opposite direction relative to that one direction.
[0173] 36. The medical implant according to any one of Examples 22 to 35, wherein the suture is at least partially formed by Armenian stitches, and / or the protective suture structure is at least partially formed by whip-like threads.
[0174] 37. The method according to any one of embodiments 22 to 36, wherein the suture or stitch structure is sewn together such that it forms two knots at the nutcracker eye at the end of the first support structure.
[0175] 38. The method according to any one of Examples 22 to 37, wherein the suture or stitch structure is sutured such that it extends through three holes in the outer skirt and / or valve assembly at the apex of the support structure, and such that the suture or stitch structure forms a clover knot.
[0176] 39. The method according to any one of Examples 22 to 38, wherein the medical implant is a heart valve prosthesis, wherein the medical implant component includes a stent structure and / or a valve assembly including at least two leaflets, wherein the valve assembly is fixed to the stent structure and extends at least partially within the stent structure.
[0177] 40. A method for manufacturing a medical implant, preferably a catheter-deliverable internal prosthesis or artificial heart valve, the method comprising the following steps:
[0178] Provides a stent structure (1), one or more skirts (5, 6, 32) and a valve assembly (3) having one or more leaflets (31); Optionally, multiple laser marks (45) are generated in the stitching area of the outer skirt, inner skirt and / or one or more leaflets, which partially penetrate the material of the outer skirt, inner skirt and / or one or more leaflets; alternatively, multiple laser holes are generated in the stitching area of the outer skirt, inner skirt and / or one or more leaflets, which completely penetrate the material of the outer skirt, inner skirt and / or one or more leaflets. The support structure (1) has a longitudinal axis (18), a circumference, a first support structure end (11) and a second support structure end (12) opposite to the first support structure end (11), and the support structure (1) surrounds the internal volume (8), and the support structure (1) has a plurality of pillars (4) forming a unit. The support structure (1) is at least partially covered by one or more skirts (5, 6, 32), such that one of the skirts (5, 6) at least partially covers the outer side of the support structure (1); The valve assembly (3) is arranged within the internal volume (8) of the stent structure, and the valve assembly (3) is secured to one or more skirts (5, 6, 32) and / or the stent structure; and One or more skirts (5, 6, 32) are secured to each other and to the stent structure and / or valve assembly such that one of the skirts (5, 6) that at least partially covers the outside of the stent structure extends at least partially to the outside of the stent structure (1), preferably extending radially outward along the circumference of the stent structure (1).
[0179] 41. A medical implant (2), preferably a catheter-deliverable internal prosthesis or artificial heart valve, comprising a stent structure (1), one or more skirts (5, 6, 32) and an optional valve assembly (3); The support structure (1) has a longitudinal axis (18), a circumference, a first support structure end (11) and a second support structure end (12) opposite to the first support structure end (11), and the support structure (1) surrounds the internal volume (8), and the support structure (1) has a plurality of pillars (4) forming a unit. One of the skirts (5, 6, 32) at least partially covers the outer side of the stent structure (1) and extends at least partially to the outside of the stent structure (1), preferably extending radially outward along the circumference of the stent structure (1), and / or the medical implant (2) includes a valve assembly (3) disposed within the internal volume (8) of the stent structure.
[0180] 42. The medical implant (2) according to Example 41, wherein the stent structure (1) has a compressible state and can be expanded to a functional state.
[0181] 43. The medical implant (2) according to Example 42 is characterized in that the skirt (5, 6) covering at least part of the outer side of the stent structure (1) has a protrusion extending radially outward around the circumference of the stent structure (1) at least in the functional state.
[0182] 44. The medical implant (2) according to any of the foregoing embodiments is characterized in that the medical implant (2) comprises only a skirt (6) that at least partially covers the outside of the stent structure (1), the skirt being at least partially or completely wrapped around the end (11) of the first stent structure and at least partially covering the inside of the stent structure (1).
[0183] 45. The medical implant (2) according to embodiment 44 is characterized in that a skirt (6) at least partially covering the outside of the support structure (1) is at least partially or entirely wrapped around the end (11) of the first support structure and is at least partially fixed, preferably sutured, glued and / or welded to itself and / or at least some of the multiple struts (4).
[0184] 46. The medical implant (2) according to any one of embodiments 41 to 43 is characterized in that the skirt (5, 6) that at least partially covers the outside of the stent structure (1) is the outer skirt (5), and optionally, the medical implant (2) further includes an inner skirt (32) that at least partially covers the inside of the stent structure (1).
[0185] 47. The medical implant (2) according to Example 46 is characterized in that the outer skirt (5) and the inner skirt (32) are at least partially fixed to each other, preferably by suturing, gluing and / or welding, and / or the outer skirt (5) is at least partially fixed, preferably by suturing, gluing and / or welding to at least some of the plurality of struts (4).
[0186] 48. The medical implant (2) according to embodiment 46 or 47 is characterized in that the inner skirt (32) does not cover the first stent structure end (11) and / or does not extend to the first stent structure end (11).
[0187] 48. The medical implant (2) according to embodiment 46 or 47 is characterized in that the outer skirt (5) covers the first stent structure end (11) and / or extends to the first stent structure end (11).
[0188] 49. The medical implant (2) according to any one of embodiments 46 to 48 is characterized in that the outer skirt (5) is fixed to each post (4) or each second post (42) of the support structure (1) along the entire circumference at the first support structure end (11).
[0189] 50. The medical implant (2) according to any one of embodiments 46 to 49 is characterized in that the outer skirt (5) has a first outer skirt edge (51) and a second outer skirt edge (52), and is folded between the first outer skirt edge (51) and the second outer skirt edge (52) to form a hook-shaped or ring-shaped structure (7).
[0190] 51. The medical implant (2) according to Example 50 is characterized in that the hook-shaped or ring-shaped structure (7) is located at the end (11) of the first stent structure.
[0191] 52. The medical implant (2) according to any one of embodiments 47 to 51 is characterized in that the first outer skirt edge (51) is fixed to the inner skirt (32) and / or the support structure (1) and / or the second outer skirt edge (52) or the hook-shaped or ring-shaped structure (7).
[0192] 53. The medical implant (2) according to any one of embodiments 47 to 52, characterized in that the edge (52) of the second outer skirt is fixed to the inner skirt (32) and / or the support structure (1).
[0193] 54. The medical implant (2) according to any one of embodiments 50 to 53 is characterized in that a first outer skirt edge (51) is fixed to an inner skirt (32) and a support structure (1), and a second outer skirt edge (52) is fixed to an inner skirt (32) and a support structure (1).
[0194] 55. The medical implant (2) according to any one of embodiments 46 to 54 is characterized in that the inner skirt (32) covers the inside of the support structure (1) on the entire circumference of the support structure (1), and / or the outer skirt (5) covers the outside of the support structure (1) on the entire circumference of the support structure (1).
[0195] 56. The medical implant (2) according to any of the foregoing embodiments is characterized in that the skirt (5, 6) or the outer skirt (5) that at least partially covers the outside of the support structure (1) has one or more pleats (70) or a pleated skirt with pleats (70).
[0196] 57. The medical implant (2) according to embodiment 56 is characterized in that the fold (70) extends in the direction from the first support structure end (11) to the second support structure end (12), or the fold (70) extends in the direction of the longitudinal axis (18), or the fold (70) bends relative to the longitudinal axis (18) at an angle of less than 30°, preferably less than 20°.
[0197] 58. The medical implant (2) according to embodiment 56 or 57 is characterized in that the folds (70) have a trumpet or bagpipe shape.
[0198] 59. The medical implant (2) according to Example 58 is characterized in that at least some or each of the trumpet-shaped or bagpipe-shaped folds forms a top opening.
[0199] 60. The medical implant (2) according to Example 59 is characterized in that at least some or each of the trumpet-shaped or bagpipe-shaped folds having a top opening additionally has a through hole 63, a slit or a side opening.
[0200] 61. The medical implant (2) according to any of the foregoing embodiments, characterized in that at least a portion of the stent structure (1), at least a portion of at least one skirt (5, 6, 32) and optional valve assembly (3) form an implant component, wherein the medical implant component defines a flow channel for guiding and / or controlling fluid flow, and the flow channel has an inlet end and an outlet end opposite to the inlet end.
[0201] 62. The medical implant (2) according to Example 61 is characterized in that the second stent structure end (12) is spaced apart from the outflow end of the flow channel.
[0202] 63. The medical implant (2) according to Example 60 is characterized in that the first stent structure end (11) is spaced apart from the inflow end of the flow channel.
[0203] 64. The medical implant (2) according to any of the foregoing embodiments is characterized in that a plurality of pillars (4) form at least two zigzag structures, tortuous structures or wavy structures, wherein each zigzag structure, tortuous structure or wavy structure extends around the entire circumference of the support structure (1), and wherein at least two zigzag structures, tortuous structures or wavy structures are connected to form a closed unit (202, 203, 204, 205), preferably a rhomboid unit.
[0204] 65. The medical implant (2) according to any of the foregoing embodiments, characterized in that the valve assembly (3) comprises one or more, preferably two or three leaflets (31).
[0205] 66. The medical implant (2) according to any of the foregoing embodiments, characterized in that one or more skirts (5, 6, 32) and / or one or more leaflets (31) include one or more laser markings (45) or laser holes.
[0206] 67. The medical implant (2) according to embodiment 65 or 66 is characterized in that the laser marking (45) is optically visible from one or both sides of the material forming one or more leaflets (31) of one or more skirts or valve assemblies (3).
[0207] 68. The medical implant (2) according to any of the foregoing embodiments, characterized in that one or more skirts (5, 6, 32), preferably inner skirt (32) and / or outer skirt (5), and / or one or more leaflets (31) of the valve assembly (3) are made of biological tissue, preferably pericardial tissue.
[0208] 69. A method for generating multiple laser marks that partially penetrate biological material, preferably biological tissue, or multiple laser holes that completely penetrate biological material, preferably biological tissue, comprising the following process steps:
[0209] - Provide biological materials, preferably biological tissues, and
[0210] - Provide a laser and process biological material, preferably biological tissue, thereby forming multiple laser marks that partially penetrate the biological material, preferably biological tissue, or multiple laser holes that completely penetrate the biological material, preferably biological tissue. Attached Figure Description
[0211] Further advantages and features of the present invention are described in the following embodiments and figures.
[0212] Figure 1A and 1B An example of a leaflet is shown. Figure 2A and 2BOther embodiments of the leaflet are shown. Figure 3 A specific embodiment of the leaflet is shown. Figure 4A and 4B An embodiment of a leaflet with laser markings or laser holes is shown. Figure 5A and 5B The illustration shows folding and stitching techniques. Figure 6A and 6B An embodiment of the inner skirt is shown. Figures 7 to 9 An embodiment of the inner skirt is shown. Figure 10A and 10B Another embodiment of the inner skirt is shown. Figure 11A and 11B An embodiment of the outer skirt is shown. Figure 12 Another embodiment of the outer skirt is shown. Figure 13A and 13B A schematic diagram of the laser-assisted sewing process is shown. Figure 14 Another schematic diagram of the laser-assisted sewing process is shown. Figure 15A and 15B The sutures used to secure the valve assembly to the stent structure are shown in the side view. Figure 15C and 15D A top view shows the protective stitch structure. Figure 15A and 15B The sutures, Figures 16A to 16H The manufacturing process steps are shown in a side view, in which the valve assembly is fixed to the stent structure. Figures 17A to 17H An example of an artificial heart valve is shown. Figure 18A and 18B Details of a medical implant are shown, which has an inner skirt and an outer skirt with a ring-like structure. Figure 18C and 18D Another embodiment of the artificial heart valve is shown in a side view. Figure 18E and 18F Another embodiment of the artificial heart valve is shown in a side view. Figure 18G and 18H Another embodiment of the artificial heart valve is shown in a side view. Figure 19 Another embodiment of the outer skirt is shown. Figure 20A and 20B Another embodiment of a medical implant with a 3D-shaped outer skirt is shown. Figure 20C A photograph of a functional TAVI / TAVR heart valve prosthesis is shown. Figure 20D It shows Figure 20C The illustration in the photo. Figure 21A and 21B The apparatus used to manufacture 3D shaped outer skirts is shown. Figure 22A and 22B Details of a medical implant with an inner skirt and an outer skirt are shown. Figure 22C and 22D The overlap of the inner skirt and the outer skirt is shown. Figure 23A and 23B An embodiment showing the outline of the support structure is illustrated. Figure 24 and 25 An embodiment of the support structure is shown. Figure 26 A portion of a first embodiment of an artificial heart valve in a functional state is shown in a side view. Figure 27 A side view shows an intermediate step in the manufacturing process. Figure 26 Implementation examples, Figure 28 Shown in top view Figure 27 The outer skirt of the embodiment, Figure 29 Shown in side view Figure 26 The inflow portion of the embodiment has an attached outer skirt. Figure 30 This shows the effect when the tubular support structure is deployed. Figure 26 The first sewing pattern of the embodiment, Figure 31 The description depicts the unfolding of the tubular support structure. Figure 26 The second sewing pattern of the embodiment, Figure 32 It shows Figure 31 Detailed view of the sewing pattern, Figure 33 A cross-section of a second embodiment of an artificial heart valve in a functional state is depicted in a side view. Figure 34 Shown in top view Figure 33 The outer skirt of the embodiment, Figure 35A The description depicts the unfolding of the tubular support structure. Figure 33 The first sewing pattern of the embodiment, Figure 35B yes Figure 35A An exploded view of the sewing pattern in an embodiment shows a suture line when the tubular support structure is deployed. Figure 35C yes Figure 35A An exploded view of the sewing pattern in an embodiment shows another suture line when the tubular support structure is deployed. Figure 35D yes Figure 35A An exploded view of the sewing pattern in an embodiment shows another suture line when the tubular support structure is deployed. Figure 36 This illustrates how the tubular support structure unfolds according to... Figure 35A The sewing pattern is stitched onto the outer skirt of the support structure. Figure 37 The description depicts the unfolding of the tubular support structure. Figure 33 The second sewing pattern of the embodiment, Figure 38 The outer skirt of the third embodiment of the artificial heart valve is shown in a top view. Figure 39 The cross-section of the outer skirt is shown. Figure 40 The laser marking pattern on the surface of the outer skirt is shown in a top view. Figure 41 The top view shows the laser marking pattern on the surface of the outer skirt to be sewn together. Figure 42 Another laser-marked pattern is shown in a top view on the surface of the outer skirt to be sewn together. Figures 43 to 45 The side view illustrates the steps of a method for manufacturing an outer skirt that attaches to the apex of a nutcracker-eye shaped support structure. Figures 46A to 46D The steps of another manufacturing method from the outer skirt to the apex of the support structure are shown in a perspective side view. Figure 47 An embodiment of a medical implant with a valve assembly having a 3D-shaped outer skirt is shown. Figure 48 Another embodiment of a medical implant with a valve assembly is shown, the valve assembly having a 3D-shaped outer skirt. Figure 49 Another embodiment of a medical implant with a valve assembly is shown, the valve assembly having a 3D-shaped outer skirt. Figure 50 A side view of another embodiment of the TAVI / TAVR heart valve prosthesis in a functional state is shown. Figure 50 A side view of another embodiment of the TAVI / TAVR artificial heart valve in a functional state is shown. Detailed Implementation
[0213] Figure 1A , 1B Images 2A, 2B, and 3 illustrate embodiments of leaflets that can be used in a heart valve assembly according to the invention. The leaflets may be made of pericardial tissue.
[0214] Figure 1A and 2B The general configuration of one or more leaflets 31 according to the first aspect of the invention is depicted. Figure 1A A corresponding embodiment of the dimensions of one or more leaflets of the present invention is shown in black. Possible dimensional variations of the above embodiments are depicted in black using dashed lines, such as arrows. Based on individual patient needs, one or more leaflets of the present invention may need to be adapted to the disclosed stent structure of the intended implantable artificial heart valve. For this purpose, one or more leaflets may need to have their configuration changed, as may be shown by the dashed lines, which may include arrows. Leaflet 31 has a ventral region, a leaflet height 71, a leaflet width 72 (free length of the edge), and a ventral length 77. The leaflet has two connecting tabs 73, each tab having a length 74 and a height 75, and an attachment distance 76 to the ventral leaflet. Each connecting tab 73 has upper and lower alignment tabs. Dashed lines illustrate possible dimensional variations of the leaflet.
[0215] Figure 2A and 2B The general configuration of one or more leaflets 31 according to the second aspect of the invention is depicted. Figure 2A A corresponding embodiment of the dimensions of one or more leaflets of the present invention is shown in black. The rectangles on the upper left and right sides emphasize the upper alignment tab. Figure 1A In contrast, in a second aspect of the invention, the lower alignment tab of the leaflet is removed from the lower part of the connecting tab 73. This exemplary configuration of one or more leaflets in the second aspect of the invention can also be used in a laser-assisted suturing process (L-ASP). If used for L-ASP, in another embodiment of the second aspect of the invention, the upper tabs can also be removed, as they are not necessary in the case of L-ASP disclosed herein.
[0216] Figure 3 A schematic overall configuration of one or more leaflets 31, also according to a second aspect of the invention, is depicted. Furthermore, Figure 3Exemplary dimensions of the configuration are shown in [mm]. In another embodiment of the second aspect of the invention, this exemplary configuration of one or more leaflets can also be used for L-ASP. If used for L-ASP, in another embodiment of the second aspect of the invention, the upper tabs can also be removed, since they are not necessary in the case of the L-ASP disclosed herein.
[0217] Figure 3 Exemplary dimensions of the leaflet, in mm, are shown. The leaflet 31 shown has a leaflet height of 17.90 mm and a leaflet width of 25.70 mm (free length of the edge). The leaflet has two joined tabs 73 with upper alignment tabs. The size of the leaflet can be adapted to the patient's anatomical dimensions according to the patient's anatomy. However, it can be maintained as... Figure 3 The relative proportions shown.
[0218] Figure 4A and 4B A schematic overall configuration of one or more leaflets 31 according to a third aspect of the invention is depicted. Furthermore, Figure 4A and 4B Various laser markings are shown, wherein the laser is required to be a suture laser mark or hole to secure the leaflet to the support structure and to secure the inner skirt element to the abdomen of one or more leaflets of the third aspect of the invention. This exemplary configuration of one or more leaflets of the third aspect of the invention is particularly suitable for L-ASP. Therefore, due to the laser suture pattern with laser marks or laser holes, this leaflet configuration does not require any alignment tabs on the connecting tabs. The laser marks or laser holes highlighted in the right rectangle are themselves used for aligning and folding the connecting tabs through the corresponding sutures. See also below Figure 5A and 5B In this case, "laser marking" simply means "laser scraping" on the top of the pericardial surface to remove only the minimum amount of material. Therefore, the laser does not create a through-hole in this case, but under a microscope, the technician performing the sewing of the skirt / leaflet components can see these markings and can more easily follow a given sewing pattern. Thus, the sewing process itself is regular. In contrast, "laser hole" indicates a complete through-hole through the pericardium to easily create a channel for subsequent sewing without using any needles. Laser marking in... Figure 4A and 4B The exemplary leaflet's abdomen is shown in a curved emphasis and will be used for fixation by stitching between the inner skirt element and the leaflet. Figure 4A and 4B An exemplary dimension of leaflet 31, in mm, is shown. Figure 4BAs shown, the distance between the laser marks 45 or laser holes on the ventral side of the lobule can be between 0.90 mm and 1.80 mm. The distance between the laser marks 45 or laser holes on the ventral side of the lobule and the ventral edge can be 1.30 mm. The distance between the laser marks or laser holes at each connecting protrusion 73 can be 3.20 mm.
[0219] Figure 5A and 5B An exemplary folding and stitching technique for one or more leaflets according to a third aspect of the invention is described. This exemplary folding and stitching technique for one or more leaflets according to a third aspect of the invention is particularly suitable for L-ASP. Figure 5B In the image, two leaflets 31 can be seen attached to a connecting post 17 of the support structure 1. Preferably, the connecting tabs 73 of each leaflet 31 are sewn to the connecting post 17 of the support structure 1 using sutures 21, 22, and 23.
[0220] Figure 6A and 6B The general configuration of one or more inner skirt elements 32 according to a fourth aspect of the invention is depicted. A corresponding embodiment of the inner skirt element and its exemplary dimensions and outline are shown in black. The lower proximal toothed portion of the inner skirt element is configured to prevent any pouch formation during the contraction and relaxation of the corresponding artificial heart valve in which the inner skirt element is implemented.
[0221] Figure 7 The general outline of one or more inner skirt elements 32 according to the fourth aspect of the invention is depicted. Furthermore, exemplary dimensions of the one or more inner skirt elements according to the fourth aspect of the invention are shown; in particular, exemplary dimensions of the proximal portion of the round teeth. Figure 7 It can be concluded that the toothed portion is configured to prevent any pocket formation during the contraction and relaxation of the corresponding artificial heart valve in which the inner skirt element is implemented. Figure 7 An exemplary dimension of the inner skirt 32, in mm, is shown. The inner skirt 32 has an inner skirt height of 24.14 mm.
[0222] Figure 8The general configuration and outline of one or more inner skirt elements 32 according to a fifth aspect of the invention are depicted. The lower proximal serrated portion of the inner skirt element is configured to prevent any pouch formation during the contraction and relaxation of the corresponding artificial heart valve in which the inner skirt element is implemented. Furthermore, in the fifth aspect of the invention, one or more inner skirt elements include laser markings 45 or laser holes for subsequently suturing the inner skirt element to another inner skirt element and the leaflet portion of the artificial heart valve. That is, laser markings or laser holes on the left and right sides are used for subsequently suturing the inner skirt element to the corresponding other inner skirt element, and laser markings or laser holes highlighted with a bend in the middle portion are used for subsequently suturing the inner skirt element to the corresponding leaflet portion. Therefore, one or more inner skirt elements according to the fifth aspect of the invention are particularly useful for L-ASP, which simplifies the overall assembly process of the artificial heart valve according to the invention.
[0223] Figure 9 The general configuration of one or more inner skirt elements 32 according to a fifth aspect of the invention is depicted, along with their exemplary dimensions and angles. The lower proximal toothed portion of the inner skirt element is configured to prevent any pouch formation during the contraction and relaxation of the corresponding artificial heart valve in which the inner skirt element is implemented. Furthermore, in the fifth aspect of the invention, one or more inner skirt elements include laser markings or laser holes for subsequently suturing the inner skirt element to another inner skirt element and the leaflet portion of the artificial heart valve. See also above. Figure 8 .like Figure 9 As shown, the distance between the laser marks 45 or laser holes can be between 0.89 mm and 1.82 mm. The distance from the laser marks 45 or laser holes to the edge of the inner skirt 32 can be between 0.92 mm and 1.30 mm.
[0224] Figure 10A and 10B The overall configuration of the inner skirt 32 elements according to the fourth aspect of the present invention is depicted. Figure 10A and 10BA corresponding embodiment of the inner skirt element dimensions of the present invention is shown in black, meaning that the lower proximal portion of the inner skirt element remains half a unit above the stent inflow portion. Possible dimensional variations of the above embodiment are depicted in black with dashed lines, such as arrows. Based on individual patient needs, the inner skirt element may have to be adapted to the stent structure for implantation of an artificial heart valve. To do this, the inner skirt element may have to be configured differently, as shown by the dashed lines, which may include arrows. The inner skirt 32 has two wings, with a wing length 321, an inner skirt height 322, an inner skirt width 323 (with respect to the half-unit inflow level), and an inner skirt free length of edge 324. The inner skirt 32 has a skirt ventral lowest point level with a width of 325. The inner skirt 32 has an inflow edge 326 of length. The toothed inflow edge may follow the stent unit but may have a different radius.
[0225] Figure 11A and 11B The overall construction and outline of the outer skirt element 5 according to the sixth aspect of the invention are depicted, along with a detailed sectional view of the distal upper portion of the outer skirt element (Hawaiian skirt configuration). The lower proximal portion of the outer skirt element with fewer serrations and the upper distal portion with more serrations are both configured to prevent any pouch formation during the contraction and relaxation of the corresponding artificial heart valve in which the outer skirt element is implemented. Furthermore, at the abdominal node, the distal upper portion of the corresponding serrations of the outer skirt is configured such that the stitching pattern of these portions is advantageous.
[0226] Figure 12 A schematic configuration, outline, and exemplary dimensions (Hawaiian skirt configuration) of an outer skirt element according to a sixth aspect of the invention are depicted. Figure 11A and 11B It can be concluded that the lower proximal portion of the outer skirt element with fewer rounded teeth and the upper distal portion with more rounded teeth are both configured to prevent the formation of any pockets during the contraction and relaxation of the corresponding artificial heart valve in which the outer skirt element is implemented. Figure 12 Exemplary dimensions of the outer skirt 5 are shown in mm. The outer skirt 5 may have a height between 12.86 mm and 15.90 mm and a width between 85.04 mm and 92.56 mm.
[0227] Figure 13A and 13BThis is a schematic diagram of a laser-assisted sewing process (L-ASP). The diagram above shows an exemplary tissue cross-section without L-ASP. The diagram on the right shows an exemplary tissue cross-section with only laser markings obtained from L-ASP, which do not fully penetrate the tissue. However, the diagram on the left shows an exemplary tissue cross-section with a complete laser through-hole obtained during L-ASP. L-ASP is a general term for sewing assistance, which indicates the location of the needle in the correct position according to the desired design by corresponding laser markings on the tissue surface. Therefore, its purpose is to ensure compliance with design requirements, improve product quality, and increase throughput by simplifying the process. According to the invention, L-ASP is intended to be used to generate either laser markings or laser holes, respectively. However, using laser markings instead of full laser holes avoids any excessive damage to the tissue, such as suture hole elongation.
[0228] Figure 14 This is a schematic diagram of the L-ASP according to the present invention. The L-ASP is used in the assembly process of the artificial heart valve of the present invention, during leaflet assembly and during skirt-to-skirt assembly. To minimize the number of laser marks or laser holes on the individual components, an alternating stitching pattern layout can be used to assemble the sub-components together: the schematic diagram on the left depicts such an alternating stitching pattern layout for the skirt-leaflet assembly of the present invention. The schematic diagram on the right depicts such an alternating stitching pattern layout for the skirt-to-skirt assembly of the present invention. In an alternative embodiment, completely mirrored laser marks or laser holes can also be used, meaning identical marks or holes on the corresponding tissue components, but this would require more marks or holes when directly compared to the alternating stitching pattern described above. The leaflets 31 are sewn to the inner skirt, which can also be made of multiple pieces sewn together.
[0229] Figure 15A and 15C An exemplary valve-stent fixation technique according to the present invention is described. The left figure illustrates an Armenian stitch used to anchor an artificial valve component to a stent; see numeral 81 and the arrow therein. Figure 15CThe diagram depicts another layer of stitches, the so-called protective stitches, applied directly over the Armenian stitches; see arrow. This is because the higher the radial force and reduced back deflection of the stent, the more likely the sutures will wear down on the stent track (so-called suture breakage). Repeated re-insertion of the artificial heart valve can also cause thinning / damage to the sutures in this critical area. Therefore, a suitable sewing pattern is needed to prevent suture thinning / damage on the stent track and to meet durability requirements. Therefore, the present invention also provides the aforementioned overlapping two series of suture patterns; namely, the Armenian stitches followed by an additional protective stitch. According to the invention, these two patterns can be of the same type or two different types. The first suture pattern anchors the valve to the stent track. The second pattern is located on top of the first pattern to further secure the valve to the track and protect the first set of stitches from damage during crimping and re-insertion. The second set of stitches further secures the first set of stitches and also limits micro-movement of the first set of stitches. Such micro-movement can also lead to wear. Figure 15C In the diagram, the first set of Armenian stitches anchors the valve onto the stent track. A second series of whip stitches covers the first set of Armenian stitches; see the arrow. Furthermore, due to this stitch configuration, the master stitch is not damaged during crimping or sheath reloading. This stitching pattern also protects the master stitch from any contact with stent structures and with the delivery catheter; for example, any contact between the delivery catheter and the artificial heart valve during sheath reloading. Additionally, the stitching pattern protects the stent from other stent components (e.g., two closely spaced struts), for example, during crimping. Given the above, the secondary stitches provide some cushioning to the master stitches. That is, with this stitch configuration, only the secondary stitches, if any, can be damaged.
[0230] exist Figure 15B and 15D The image shows the attachment of a valve assembly with an inner skirt 32 or an outer skirt (not shown) to a stent structure 1 and its struts 4. Figures 15A to 15B Multiple Armenian stitches 81 are shown, which together form the first suture and the "clove knot" 83 at the apex of the support structure. (See diagram.) Figures 15C to 15D As shown, a protective stitch structure formed by individual whip-like stitches 82 covers the Armenian stitch 81. The protective stitch structure has the advantages detailed above. Figure 15A Closed units 401, 402, and 412 are shown, which are formed by four pillars 4 and each has four vertices 84. Unit 512 is adjacent to a connecting pillar 17.
[0231] Figure 16A , 16C16E and 16G depict exemplary sewing processes for artificial heart valves according to the invention. The sewing patterns are characterized in that, in each case, a support is used to apply Armenian stitches and a protective stitch to reinforce the suture. The exemplary sewing process is as follows: Starting from the top of the connecting track (connecting support), the valve is first attached to the support structure 1 using Armenian stitches. Then, the Armenian stitches continue until the bottom of the track (support) 4. Once the Armenian stitches on the track / support are complete, the same thread is used to "return to the track" with a "whip stitch" (3). Thus, the whip stitches (i.e., the protective stitches) cover the Armenian stitches (first sewing pattern) along the entire length of the track / support and continue until they are subsequently secured to the connecting tab (4).
[0232] Figure 16B , 16D 16F and 16H illustrate the suturing process of the first suture and the protective stitch structure, wherein Armenian stitch 81 is first provided to secure the inner skirt 32 to the support structure 1 (see Figure 1). Figures 16A to 16D Starting from the top of the connecting post 17 (also called the connecting strut, connecting tab, or connecting track), the inner skirt 32 is first attached to the support structure 1 using Armenian stitch 81. Then, the Armenian stitch 81 continues until the bottom of the strut ( Figures 16A to 16D Once the Armenian stitch 81 on the support is completed, the same thread is used to return to the support in whip stitch 82. Figures 16E to 16H Therefore, the whip-like stitches 82 cover the Armenian stitches 81 (first sewing pattern) along the entire length of the post and continue to the joint post where they are subsequently fixed.
[0233] Figure 17A , 17C Images 17E and 17G show photographs of various exemplary embodiments of the outer skirt element according to the sixth aspect of the present invention (Hawaiian skirt configuration). Figure 17A The Hawaiian skirt configuration, schematically illustrated, is designed to prevent any periocular leakage by increasing the contact surface with anatomical structures within the annular region (also in the peripheral region, the subannular region (LVOT), and the supraannular region (natural lobule)). For this purpose, the aforementioned suture pattern is chosen such that when the prosthesis is rolled down to the IFU implantation diameter, the resulting unrestricted outer skirt surface folds, thereby increasing contact with the anatomical structures. In the Hawaiian skirt configuration, the skirt circumference is equal to the support at the abdominal level and the inflow level. The skirt height is equal to the support height between the inflow and the lowest point of the abdomen. Sutures in the first zigzag row of the support are selectively restricted by dashed lines (e.g., Figure 17E As shown), when the prosthesis curls downwards to the IFU implant diameter range (see... Figure 17GWhen the outer skirt surface is folded, it takes on a shape resembling a Hawaiian skirt. The Hawaiian skirt configuration is designed so that no blood is trapped within it. The Hawaiian skirt can be made from pericardium such as porcine or bovine pericardium, or fabrics such as polyethylene or polyurethane. Also according to... Figure 10A The top (lowest point of the abdomen) of the Hawaiian skirt configuration (i.e., the upper distal portion) is serrated to conform to the support. All its peaks have the same height. According to the invention, it is sewn to the inner skirt element, but in some supports / tracks, the outer skirt element in the Hawaiian skirt configuration is unrestrained (see...). Figure 17E (The dotted lines highlight the corresponding sewing pattern). In one embodiment, the near-bottom of the inflow point can be selected from (i) serrated or (ii) rounded.
[0234] Figure 17B The heart valve prosthesis 2 in the middle shows Figure 17A The image shows a photograph. The heart valve prosthesis includes a stent structure 1 and a valve assembly 3. The stent structure has a compressed state (not shown) and a functional state (shown). The stent structure 1 has a first stent structure end 11 and a second stent structure end 12, a longitudinal axis (not shown), and multiple struts 4 forming multiple units.
[0235] The stent structure (1) surrounds the internal volume (8), within which the valve assembly 3 is located. The valve assembly 3 is fixed to the connecting post 17 of the stent structure (1).
[0236] The heart valve prosthesis includes an outer skirt 5 that partially covers the outer side of the stent structure 1 and an inner skirt 32 that at least partially covers the inner side of the stent structure 1.
[0237] The stent structure has a (proximal) inflow portion and an outflow portion, as well as at least one intermediate portion (also referred to as a transition zone) disposed between the inflow and outflow portions. The inflow portion of the stent structure, the inner skirt 32 (located in the intermediate portion of the stent structure), the valve assembly 3 (located in the intermediate portion of the stent structure), and the optional outer skirt 5 (located in the inflow portion of the stent structure) together form an implant component. The medical implant component defines a flow channel for guiding and / or controlling fluid flow (e.g., blood flow). The flow channel has an inflow end (located in the inflow portion of the stent structure) and an outflow end (located in the intermediate portion of the stent structure). A first stent structure end 11 is located at the inflow end of the flow channel. A second stent structure end 12 is located spaced apart from the outflow end of the flow channel (when viewed along a longitudinal axis not shown here, but see...). Figure 27 ).
[0238] Figure 17D It shows Figure 17CThe image shows a photograph of the medical implant 2. The medical implant 2 includes a stent structure 1, a valve assembly 3, and an outer skirt 5 that partially covers the outside of the stent structure 1 and together forms the implant component.
[0239] The stent structure 1 has a first stent structure end 11 and a second stent structure end (not shown) and a plurality of struts 4. The stent structure 1 surrounds an internal volume 8, in which the valve assembly 3 is located. The valve assembly 3 is fixed to the connecting post 17 of the stent structure 1.
[0240] The medical implant component defines a flow channel for guiding and / or controlling the flow of fluid (e.g., blood flow). The flow channel has an inflow end (first stent structure end 11) and an outflow end (spaced apart from the second stent structure end 12 in the longitudinal direction (along the longitudinal axis).
[0241] The support structure can be in a compressed state and can expand in a functional state.
[0242] Figure 17F It shows Figure 17E The image of medical implant 2 ( Figure 17C and 17D (Close-up).
[0243] The medical implant has a scaffold structure 1 with multiple struts 4 forming one or more zigzag, tortuous, or wavy structures, each extending around the entire circumference of the scaffold structure 1. A zigzag, tortuous, or wavy structure at one end 11 of the scaffold structure forms half-units 101, 102, 103, 104, and 105. The half-units are surrounded by a first strut 41 and a second strut 42. Two zigzag, tortuous, or wavy structures are connected to form closed units 202, 203, 204, and 205.
[0244] As can be seen, the outer skirt is fixed (e.g., sutured) to each second strut 42 of the strut structure to the half-unit along the entire circumference of the support structure, thereby forming folds (in the fold-generating portion). These folds enable better sealing of the medical implant. Fixation is accomplished by three sutures 21, 22, and 23 attached to the struts of the support structure. Thus, the fold-generating portion of the outer skirt 5 is formed along the zigzag structure 13 of the support structure 1. Furthermore, along the zigzag structures 14 and 15, the outer skirt 5 is fixed to each strut, thereby forming a sealing portion.
[0245] Figure 17H The heart valve prosthesis 2 in the middle shows Figure 17GThe image shows a photograph. The heart valve prosthesis 2 has a support structure 1 having multiple closure units 202 and multiple half-units 101, both formed by multiple struts. Half-units are located at a first support structure end 11 and a second support structure end (not visible), respectively. Each half-unit is formed by a first strut 41 and a second strut 42. At least one closure unit is formed by the first strut 41, the second strut 42, and two additional struts. The heart valve prosthesis 2 has an outer skirt 5, which is attached to each second strut 42 of the half-unit located at the first structural end 11. The outer skirt 5 is attached to each closure unit connected to the half-unit located at the first structural end 11. The artificial heart valve 2 has a valve assembly 3 attached to the inside of the support structure 1.
[0246] Figure 18A , 18C Figures 18E and 18G illustrate various exemplary embodiments (primrose configurations) of the outer skirt 5 element according to the seventh aspect of the present invention. Figure 18A , 18C The primrose configuration, schematically illustrated in 18E and 18G, is constructed to prevent any periovalvular leakage by increasing the contact surface with anatomical structures within the annular region (also in the peripheral region, subannular region (LVOT), and supraannular region (natural leaflet)). For this purpose, the outer skirt element in the primrose configuration employs a washer-like structure. That is, in the primrose skirt configuration, the circumference of the skirt is equal to the stent at the ventral and inflow levels. The height of the outer skirt is longer than the stent height between the lowest point of the ventral region and the stent inflow, because during the assembly of the heart valve prosthesis, the outer skirt of the primrose configuration should fold along the longitudinal axis of the stent. This creates a washer-like structure (composed of at least two layers of pericardium stacked). Furthermore, by stitching specific points of the outer layer to the stent to drive the fold only circumferentially, the outer skirt of the primrose configuration can be forced to have no / negligible axial slack. The outer skirt element of the primrose configuration can be made from pericardium, such as porcine or bovine pericardium, or from fabrics such as polyethylene or polyurethane. Figures 18C to 18H A medical implant 2 with a valve assembly 3 is shown, the valve assembly 3 having leaflets 31 and a primrose-configured outer skirt 5. (See diagram) Figure 18A As shown, the outer skirt has a first outer skirt edge 51 and a second outer skirt edge 52, and is folded between the first outer skirt edge 51 and the second outer skirt edge 52 to form a double-layered outer skirt with a hook-shaped or ring-shaped structure 7. The hook-shaped or ring-shaped structure 7 is located at the first support structure end 11 and / or the inflow end of the flow channel. The first outer skirt edge is fixed to the inner skirt edge 32 and the support structure 1, and the second outer skirt edge 52 is fixed to the inner skirt edge 32 and the support structure 1. Figure 18D , 18F Figures 18H and 18H show the sequence of manufacturing steps for the primrose arrangement. Figure 18DIn this configuration, the outer skirt 5 is placed on the outer surface of the support structure 1 and assembled with the inner skirt 32 (the proximal portion). The outer skirt 5 is completely fixed to the support structure 1 up to the first support structure end 11. Figure 18F A view of the interior of the prosthesis is shown. Figure 18H The outer skirt 5 is shown to fold itself and eventually be bound together with the inner skirt 32 at a half-unit along the circumference of the support structure 1 (just below the lowest point of the abdomen). Furthermore, for the hook-shaped or ring-shaped structure 7, the outer skirt 5 may have pleats 70.
[0247] Figure 19 An exemplary outline of the outer skirt element of the present invention, having corresponding dimensions, in a primrose configuration, is shown. From Figure 19 It can be concluded that, in one embodiment, both the upper distal portion and the lower proximal portion of the outer skirt element can be serrated. In another embodiment, the lower proximal portion of the outer skirt element in the primrose configuration can be serrated, as shown by the dashed line. Figure 19 Exemplary dimensions of the outer skirt 5 are shown in mm. The outer skirt 5 may have a height between 24.5 mm and a width between 83 mm and 95 mm.
[0248] Figures 20A to 20D Two exemplary embodiments (3D shape configurations) of the outer skirt element according to the eighth aspect of the invention are shown. The 3D shape configuration is configured to prevent any periocular leakage by increasing the contact surface with the anatomical structures within the annular region (as well as in the surrounding region, the sub-annular region (LVOT), and the supra-annular region (natural leaflet)); particularly in the presence of any calcified nodules, and to increase fluid resistance to backflow. Therefore, the 3D shape configuration includes a shell structure formed with one or more structures circumferentially raised / protruding from the shell plane, such as… Figure 20A and 20C One or more bubble-like structures are shown. In one embodiment of the invention, these lift / protrusion structures may have different sizes and shapes, and are therefore not limited to bubble-like structures. In one embodiment, the lift / protrusion structures are already present when the artificial heart valve of the present invention is in a fully expanded state; see also Figure 20A In the 3D shape configuration, the perimeter of the outer skirt element is equal to the stent at the abdominal level and the inflow level. The height of the outer skirt element is equal to the stent height between the inflow and the lowest point of the abdomen. Furthermore, the intention of utilizing the 3D shape configuration is to prevent blood trapping, such as the formation of any pockets. When the artificial heart valve of the present invention is rolled down to the IFU implantation diameter, the lift / protrusion structure will slightly readjust in shape due to the change in stent geometry. The upper distal portion (lowest point of the abdomen) of the 3D-shaped outer skirt element is serrated to conform to the unit profile of the stent (see...). Figure 20AEach vertex has the same height and is also sewn together with the inner skirt element of the present invention. The lower proximal portion of the 3D-shaped outer skirt element (at the inlet of the support) can be selected from (i) serrated or (ii) rounded. The 3D-shaped outer skirt element can be made of pericardium such as pig or bovine pericardium or of fabric such as polyethylene or polyurethane.
[0249] Figure 20D A medical implant 2 in a functional state is shown. The medical implant 2, preferably a catheter-deliverable internal prosthesis, includes a stent structure 1, an inner skirt 32, an outer skirt 5, and a valve assembly 3. The stent structure has a first stent structure end 11 and a second stent structure end (not shown) opposite the first stent structure end 11, and wherein the stent structure 1 surrounds an internal volume 8, and wherein the stent structure 1 has a plurality of struts 4 forming units 101. The outer skirt 5 partially covers the outer side of the stent structure 1 and completely covers the first stent structure end 11. The inner skirt 32 partially covers the inner side of the stent structure 1. The valve assembly 3 is disposed within the internal volume 8 of the stent structure.
[0250] Figure 21A and 21B An apparatus 99 for manufacturing the outer skirt element of the 3D shape configuration of the present invention is depicted. If the outer skirt element is made of pericardium, such as porcine pericardium, it is obtained from the porcine pericardium through a process in which the central pericardium is compressed within two shells: i) a positive POM molding die for the final shape and a negative polyurethane foam, while undergoing a specific treatment with glutaraldehyde (GA) for more than 4 to 14 days, with the glutaraldehyde being replaced every 2 days, in order to chemically crosslink the tissue into the desired 3D shape; for example, with different lift / protrusion structures. During this process, temperature, applied pressure, and other physical parameters are controlled.
[0251] Figure 21B This illustrates the use of 3D-molded outer skirt components ( Figure 35A The apparatus comprises a top plate 69 (with holes allowing solvent to pass through) and a mold holder 67 having a 3D forming mold 65. The mold holder and the 3D forming mold can be one or more pieces. The top plate 69 can be secured to the top of the 3D forming mold 65 and / or the mold holder 67 by means of fixing devices 66a, 66b. A sponge 68 can be arranged between the top plate 69 and the 3D forming mold 65 and / or the mold holder. The sponge 68 can have a compression hardness of 60 kPa.
[0252] Figure 22A and 22C These are two schematic diagrams illustrating the overall overlap between the inner skirt element and the outer skirt element according to the invention. Figure 22A and 22CFrom this, it can be deduced that, in this embodiment, the inner skirt has a serrated upper distal portion and a serrated lower proximal portion, so as to be tightly and completely sewn onto the contour of the stent structure unit, thereby avoiding the formation of any pockets and trapping any blood.
[0253] exist Figure 22B In the medical implant 2, the outer skirt portion 5 is partially fixed to the inner skirt portion 32 and / or the support structure 1. However, the first outer skirt edge 51 is only fixed to the first support structure end 11. The inner skirt portion 32 does not cover the first support structure end 11 and does not extend to the first support structure end 11.
[0254] Figure 22D The overlapping of the outer skirt 5 and the inner skirt 32 is shown, which are made of three pieces attached to each other.
[0255] Figure 23A and 23B : A schematic diagram of the external contour of the stent structure according to the invention. Z1 represents a conical-convex inflow region / part (annular region) defined by a first diameter D1 and a second diameter D2 (“abdominal lowest point” diameter), D1 being larger than D2, and the outer surface of this region Z1 is characterized by its outward curvature in the longitudinal direction (convex or hyperboloid, respectively). Following region Z1 is a single conical valve region Z2 (valve region) having a cone shape opposite to Z1, Z2 being defined by a first diameter D2 and a second diameter D3 (so-called attachment diameter), the first diameter being the smallest diameter of the entire vascular implant, further characterized in that the first diameter D2 is smaller than the second diameter D3. Following region Z2 is a cylindrical and therefore straight outflow region Z3 (outflow region), characterized in that the diameter D3 remains constant throughout region Z3. This results in the so-called “direct outflow” of the vascular implant. Finally, next is the connector region Z4. In one design, the connector region may consist of three connectors. In another design, the optional three connectors may be monofilaments and inwardly curved, and also have damage-resistant tip elements (not shown). For example, the first diameter D1 can be 29.5 mm, the second diameter D2 can be 25.5 mm, and the third diameter D3 can be 26.5 mm.
[0256] Figure 24 According to the present invention and based on Figure 23A and 23BA schematic diagram of the stent structure is shown. Z1 represents a conical-convex region defined by a first diameter D1 and a second diameter D2 (“abdominal lowest point” diameter), where D1 is larger than D2, and the outer surface of this region Z1 is characterized by its outward curvature in the longitudinal direction (convex or hyperboloid, respectively). Following region Z1 is a single conical valve region Z2 (valve region) having a conical shape opposite to Z1, where Z2 is defined by a first diameter D2 and a second diameter D3 (so-called attachment diameter), the first diameter being the smallest diameter of the entire vascular implant, further characterized in that the first diameter D2 is smaller than the second diameter D3. Following region Z2 is a cylindrical and therefore straight outflow region Z3 (outflow area), characterized by the diameter D3 remaining constant throughout region Z3. This results in the so-called “direct outflow” of the artificial heart valve. The upper boundary of the stent structure is a connector region Z4, which, in the illustrated design, can consist of three connectors. In one design, the connectors (optionally three) can be monofilament, inwardly curved, and have damage-resistant tip elements (not shown).
[0257] Figure 25 According to the present invention and based on Figure 23A and 23B A schematic diagram of a stent structure with distinctive features. The design shown is characterized by a number of units in the circumferential direction of the inflow region a), the number of which is divisible by 3 to ensure 1 / 3 symmetry. It is further characterized by an additional number of units in the circumferential direction in the outflow region b), which is also divisible by 3, but less than the number of units in the inflow region a). Regions a) and b) are connected by a so-called transition region c (transition zone), which ensures the connection between the inflow region a) and the outflow region b), and includes the largest unit of the stent structure 3) in this configuration for free access to the coronary artery. According to... Figure 25 In the preferred configuration, the inflow area includes 12, 15 or 18 units (1), and the outflow area includes 3, 6 or 9 units (2).
[0258] The invention is explained below with respect to various embodiments of artificial heart valves. However, the invention can be similarly applied to other medical implants, such as other (catheter-deliverable) implantable prostheses or stents.
[0259] Reference Figures 26 to 27 Sections 29 to 32 explain a first embodiment of an artificial heart valve. The heart valve prosthesis includes a tubular stent structure 1 and a valve assembly 3, both forming implant components. The stent structure has a compressible state (not shown) and a functional state (e.g., Figure 26 and 27 (As shown). Furthermore, the support structure 1 has a first support structure end 11 and a second support structure end 12 (see...). Figure 27), longitudinal axis 18 (see Figure 27 ) and multiple zigzag structures 13, 14, 15, forming a unit pattern with multiple units (see Figures 29 to 32 The outline of the medical implant component. Each closure unit (e.g., units 202, 203, 204, 205) near the first scaffold structure end 11 of the scaffold structure is formed by two adjacent zigzag structures (e.g., zigzag structures 13, 14) fixed to each other at their respective vertices. Thus, each closure unit is formed by four pillars. The units have different sizes along the prosthesis. At the second scaffold structure end, a retention device (e.g., an eyelet) for connection with a catheter can be provided.
[0260] Valve assembly 3 is located within stent structure 1 and has three leaflets 31 and an inner skirt 32, wherein the leaflets 31 and inner skirt 32 are fixed to each other by suturing in a known manner. Furthermore, valve assembly 3 is fixed to stent structure 1 by suturing, for example at commissural post 17.
[0261] The prosthesis defines a flow channel from the first stent structure end 11 (forming an inflow portion) to the end of the valve assembly 3 opposite to the first stent structure end 11 (forming an outflow portion) through the valve assembly 3. Fluid flow (e.g., blood flow) through the flow channel is controlled by leaflets 31, which can be in a closed state and an open state.
[0262] The outer diameter of the stent structure 1 is larger at the first stent structure end 11 than at the middle portion. Furthermore, the outer diameter of the stent structure 1 at the middle portion is smaller than the outer diameter of the stent structure at the second stent structure end 12. The horizontal point of the stent structure with the smallest diameter along its longitudinal axis 18 is referred to as the lowest point of the abdomen.
[0263] In addition, before being attached to the support structure, the prosthesis includes, for example, Figure 28 The outer skirt 5 is shown. The outer skirt 5 is a slightly curved rectangular (biological) tissue. The first edge 51 of the outer skirt has a serrated shape, while the second edge 52 of the outer skirt 5 is serrated. The dimensions of the vertices of the shapes at the first edge 51 and the second edge 52 allow them to attach to the vertices of the corresponding zigzag structures 13, 15 of the support structure 1, to follow the support structure 1. The outer skirt 5 of this embodiment achieves an attachment in the form of a "Hawaiian skirt," based on the concept of a valve medial wall skirt. Figure 28 The circumference (i.e., width) of the outer skirt 5 shown is equal to the circumference of the support structure 1 at the abdominal level and at the inflow end of the flow channel or at the first support structure end 11. The height of the outer skirt 5 is equal to the height of the support structure between the inflow end 11 and the lowest point of the abdominal section.
[0264] according to Figure 29 and 30The first suture pattern shown depicts the outer skirt 5 (which may be a monolithic biological tissue or a polymer sheath) sutured to the scaffold structure along three zigzag structures 13, 14, and 15. The sutures are provided by sutures, with each suture 21a, 22a, and 23a extending along the three zigzag structures 13, 14, and 15. Lines 21a, 22a, and 23a symbolize that the suture stitches in these areas pass through the thickness of the outer skirt and secure it to the scaffold. Lines 21b, 22b, and 23b symbolize that the sutures only wrap around the corresponding struts in that area of the scaffold structure without passing through the outer skirt 5. Thus, along the zigzag structure 13 of the scaffold structure 1, a folded portion of the outer skirt 5 is formed.
[0265] By selectively restricting the sutures in the lowest zigzag structure 13 of the support structure 1, the resulting unrestricted outer skirt 5 surface folds when the prosthesis is rolled downwards into a compressed state. In this configuration, the outer skirt 5 presents a shape that resembles a Hawaiian skirt. The structure of a Hawaiian skirt has been explained in detail above.
[0266] The outer skirt 5 can be made of pericardium, such as pig or cow pericardium, or of fabric, such as polyethylene or polyurethane. For sealing purposes, the second edge 52 of the outer skirt 5 can be sewn together with the inner skirt 32 or a strip element.
[0267] Figure 31 A Hawaiian-style sewing pattern is shown, wherein the first seam 26 extends only along the zigzag structure 15 (located between units 401 to 415 and units 301 to 315). Second and third seam lines 24 and 25 extend alternately along zigzag structures 13 and 14, wherein, as described above, along zigzag structures 14 and 15, the outer skirt 5 is secured to each post forming the sealing portion, and along zigzag structure 13, the outer skirt 5 is secured to each second post, thereby forming the fold-generating portion.
[0268] Sutures 21, 22, 23 or 24, 25 can be produced continuously around the entire circumference, so that the next suture structure achieves a self-locking effect relative to the already produced structure.
[0269] Figure 32 The direction of the sutures 24 forming the sutures is shown to vary along the support structure 1. On the outside of the support structure 1, the single stitches 24c of the sutures 24 at the zigzag structure 13 extend substantially perpendicular to the longitudinal direction 18, while the single stitches 24d of the sutures 24 at the zigzag structure 14 extend substantially along the longitudinal direction of the support structure 1. Furthermore, the arched stitches 24e along the pillars on the right-hand side of unit 108 symbolize that the corresponding sutures 24 are wrapped around the corresponding pillars without securing the outer skirt 5 to the support structure 1 there.
[0270] Figures 33 to 37 A second embodiment of the artificial heart valve is shown. Compared to the first embodiment, the folded portion of the outer skirt is now further away from the outflow end of the flow channel than the sealing portion.
[0271] like Figure 33 As shown, each through-hole 63 is accommodated at one end of a conical, slightly laterally curved fold 64, forming a "bagpipe" structure. Thus, the through-holes are accommodated within the intermediate zigzag structure 14 between the supports, forming a "V" shape opening towards the outflow end of the flow channel. Alternatively, the through-hole 63 can be replaced by a slit or a semicircle. In the bagpipe skirt configuration, blood is not trapped but redirected. Blood is guided through the fold 64 in the top opening of the outer skirt 5 and radially redirected through the through-holes 63, preferably the side openings. The "bagpipe structure" in Figure 36 The middle section is shown in the top row of the markers. Because... Figure 35A and 37 As shown in the specific sewing pattern, the outer skirt 5 of this embodiment is configured to predictably fold into a bagpipe-shaped structure.
[0272] Outer skirt 5 Figure 34 As shown in the diagram, the outer skirt 5 has a rectangular, straight shape. The second edge 52 of the outer skirt 5 can be straight (as shown here) or serrated. The first edge 51 of the inflow end of the flow channel can be selected from serrated, serrated, or straight. Furthermore, the outer skirt 5 has a row of slit-like through-holes 63 positioned parallel to the second edge 52. The apexes of their serrations all have the same height. For sealing purposes, the lower part of the outer skirt 5 near the inflow end of the flow channel is sewn together with the inner skirt 32.
[0273] like Figure 35A As shown, a first embodiment of the sewing pattern may include three sutures 27, 28, and 29 that extend completely over three adjacent zigzag structures 13, 14, and 15 at the first support structure end 11, extending circumferentially and passing through the entire height of the outer skirt 5. The sutures 27, 28, and 29 are arranged sequentially around the circumference of the support structure 1, thereby achieving a self-locking effect of one suture to the next. Two adjacent zigzag structures 13 and 14 are covered by the sealing portion of the outer skirt 5, where the outer skirt 5 is sewn to each post of these zigzag structures 13 and 14. There, a continuous line is used to represent the thickness of the stitches passing through the outer skirt 5 and to secure it to the support structure 1. At the upper zigzag structure 15, located further away from the flow channel, every other post is not secured to the support structure forming the fold-generating portion, indicated by dashed lines, where the suture is wrapped around the post without passing through the outer skirt 5. For better illustration... Figure 35A ,exist Figure 35B , 35C Individual sutures 27, 28, and 29 are shown in 35C, respectively.
[0274] The outer skirt 5 can be made of pericardium, such as pig or cow pericardium, or of fabric, such as polyethylene or polyurethane.
[0275] Figure 37 The sewing pattern shown includes seam lines 35, 36, and 37, with seam line 35 located only at the end 11 of the first support structure extending along the zigzag structure 13. The other seam lines 36 and 37 extend along two sequentially arranged zigzag structures 14 and 15 to achieve the aforementioned self-locking effect. The positions of the sealing portion and the folding portion are related to... Figure 35A The positions are the same.
[0276] In a third embodiment of the heart valve prosthesis of the present invention, a so-called primrose configuration or ox-lip shape is achieved. Figure 38 The diagram shows an outer skirt 5, which is (biological) tissue folded along fold line 53 to form a hook-shaped or ring-shaped structure 7 (double outer skirt), or located as... Figure 18B The inflow end of the flow channel is shown. The first edge 51 and the second edge 52 of the outer skirt 5 are serrated. In another embodiment, the first edge 51 of the outer skirt 5 in the primrose configuration can be rounded, such as... Figure 38 As shown by the dashed line 51 in the figure.
[0277] The outer skirt 5 is sequentially sewn to the adjacent zigzag structures 13 and 14 located at the end 11 of the first support structure using two sutures to achieve a self-locking effect, thus providing a sealed portion. Then, as... Figure 18B The outer skirt 5 is folded so that its middle portion completely covers the sealing portion from the outside. A further portion of the outer skirt 5 located at the outlet end of the flow channel is sewn to another zigzag structure 15 via a third seam 40, which is further away from the outlet end of the flow channel than zigzag structures 13 and 14. The third seam 40 sewn the outer skirt 5 to all the supports of the zigzag structure 15 along the entire circumference.
[0278] The third embodiment aims to prevent and limit the occurrence of any PVL by increasing the contact surface with the anatomical structures within the annular region and adjacent regions (lower annular (LVOT) and upper annular (natural leaflet)).
[0279] To further improve stitch quality and simplify the stitching process, the outer skirt 5, 6, or the inner skirt 32 may include laser markers 45, each located at a position where stitches can subsequently be provided. As an example, this is in... Figure 39The outer skirt 5 is shown in the diagram. Each laser mark 45 penetrates only partially into the thickness of the outer skirt 5. In the laser marking method, the point to be punctured is identified by locally engraving the surface of the biological tissue. Unlike holes, laser marks 45 preserve most of the biological structure of the tissue, thus minimizing damage to the structural integrity of the material. It can be observed that the laser marks 45 only partially penetrate the tissue thickness. By appropriately adjusting the power and speed of the laser, laser marks of sufficient depth can be identified. These marks should be large enough for the operator to see during sewing, yet small enough to have minimal impact on the overall structure of the tissue. This can be achieved by appropriately adjusting the speed and power of the laser used to cut tissue components (e.g., inner skirt tissue 33). To create the laser marks (L-ASP), small circles with diameters between 0.01 mm and 0.06 mm are used in CAD software. The CAD file can then be converted into a cutting file. Laser parameters can be selected as follows: power = 3.5–7%, speed = 10%, PPI (dots per inch) = 500. However, a balance must be struck between the number of circles and the error rate when importing data into the cutting file. The more circles in the cutting file, the larger their diameters must be to ensure complete import into the laser cutting machine software, as small circles can lead to data loss during import. However, the circles should be small enough that the laser markings (45) are not too large.
[0280] Figure 40 An outer skirt with laser markings 45 is shown, which can be sewn together when the outer skirt is folded.
[0281] exist Figure 41 and 42 The image shows two tissues, 33 and 34, that need to be sutured together. Figure 41 The image shows the dual-pattern topology of laser mark 45. Figure 42 The alternating pattern topology of laser marking 45 is shown in the figure. Figure 42 The spacing of the laser markings in the middle is 45. Figure 41 The laser marking spacing is twice that of 45mm. Regarding... Figure 41 The two tissues 33 and 34 are aligned with the two laser marks 45 positioned exactly above each other. This means that during suturing, each stitch passes through both laser marks 45. Figure 42 In the alternating patterning technique shown, laser marks 45 are separated by a distance twice the spacing length. With proper alignment, tissues 33 and 34 have a displaced position relative to the laser marks 45 on the reference layer, such that the superposition of the two tissues 33 and 34 gives the target spacing. This means that each stitch has only one mark 45 indicating the correct point.
[0282] exist Figures 43 to 45 and Figures 46A to 46DThe diagram shows the stitching of the thread and outer skirt (5, 6) to the terminal apex, such as the nutcracker eye 85 or the apex 88 of the two supports. This stitching enables the outer skirt 5 (e.g., a layer of soft material) to be securely attached to the supports of the rigid support structure.
[0283] The first embodiment relates to the inflow fixation on the nutcracker eye 85, including suturing from the inside of the support structure through 90, vertically pulling the suture around the eye 85, and simultaneously passing a needle through the outer skirt 5 and making the ring 91 upright (see...). Figure 43 Then, at point 90, perform a single knot 92 and sew it again under the flowing post (see...). Figure 44 At position 93 on the right, sew from the inside, close to the bottom of the block near the nutcracker eye, pulling the stitch horizontally around the flow into the support while passing the needle through the outer skirt and keeping loop 94 upright. Again close to the bottom of the block, use the created loop 95 to make another single knot.
[0284] The second embodiment involves stitching a zigzag structure of a metal support structure 1 with struts at vertices 88 to the inflow contour of an inner and / or outer skirt made of, for example, pericardium. The process is divided into four implementation steps: standard stitching of the outer skirt 5 using whip stitches until reaching the vertices 88 of the zigzag structure; the sutures should be taut (…). Figure 46A Then, the suture is wrapped around the support from the outside without piercing the tissue of the outer skirt 5, and then the skirt is pierced from the inside of the prosthesis through different holes 97 (not the same holes as the previous whip stitches), exactly at the center of the zigzag structure apex gap. The suture should not be tightened at this point; instead, the loose loop 97a should be left open to allow for the next step (…). Figure 46B Afterward, the suture is wrapped around the scaffold structure again from the outside without piercing the suture, while crossing through the loop 97a left in the previous step (see above). The suture should remain behind the previous suture (towards the outflow point, i.e., towards the center of the unit) to allow for the crossing. Then, on the other side of the unit, the tissue is pierced with different holes 98 along the inner contour of the strut (relative to the whip stitch performed at the beginning of the operation). Ideally, this suture hole 98 should be symmetrical (mirror image) with respect to the vertical (long) axis of the rhombus / unit of the scaffold structure to the last whip stitch / hole. At this point, on the tissue surface of the outer skirt 5, within the zigzag apex gap, there will be 3 different suture holes (whip stitch holes 97, 98), placed in the gap and forming an equilateral triangle (ideally). The suture should be tightened at this point (see above). Figure 46C Then, according to the desired sewing pattern parameters and specifications (see...). Figure 46D The standard whip-like needle mark 99 can continue along the support structure pillar.
[0285] Figures 47 to 49An embodiment of a medical implant 2 is shown, having a scaffold structure and a 3D-shaped outer skirt 5, and optionally a valve assembly 3. The outer skirt 5 has protrusions 20 on its outer surface. The outer surface of the outer skirt is the surface facing an anatomical structure (e.g., tissue, blood vessel, or organ) at the implantation site. The outer skirt 5 may have a cylindrical shape. The 3D shape is pre-formed during the manufacturing process of the outer skirt 5. The medical implant 2 may have a compressed state and may expand into a functional state. The medical implant 2 is shown in its (expanded) functional state. Furthermore, when the medical implant is rolled down for IFU implantation, the 3D structure may slightly readjust in shape due to changes in scaffold geometry.
[0286] Figure 47 A medical implant 2 with pleats, elongated channels, or turbine-like structures on the outer skirt 5 is shown.
[0287] Figure 48 A medical implant 2 with nail-like protrusions on the outer skirt 5 is shown.
[0288] Figure 49 A medical implant 2 is shown with air bubbles (spherical, globular, ellipsoidal, or shapes obtained by cutting these solids with a plane) on the outer skirt 5. The second end of the skirt may be serrated to follow the support. The second outer skirt 5 is sutured to the inner skirt (not visible). The second end of the skirt at the outflow end of the flow channel may be serrated (see...). Figure 49 ), round teeth (see) Figure 48 ) or even flat (see Figure 47 ).
[0289] Figure 50 A side view of another embodiment of a medical implant 2 in a functional state is shown. The medical implant 2, preferably a catheter-deliverable internal prosthesis, includes a stent structure 1, a skirt 6, and a valve assembly 3. The stent structure has a first stent structure end 11 and a second stent structure end (not shown) opposite the first stent structure end 11, and wherein the stent structure 1 surrounds an internal volume 8, and wherein the stent structure 1 has a plurality of struts 4 forming units 101. The medical implant 2 includes only one skirt 6 that partially covers the outer side of the stent structure 1, the skirt completely wrapping around the first stent structure end 11 and partially covering the inner side of the stent structure 1. The valve assembly 3 is disposed within the internal volume 8 of the stent structure. Depending on how the skirt is attached to the stent structure and / or whether the skirt has a 3D shape structure, the skirt 6 that partially covers the outer side may extend at least partially to the outside of the stent structure 1, preferably radially outward to the circumference of the stent structure 1. This means that the skirt 6 that partially covers the outer side has protrusions. These protrusions may be folds or suction cup-like protrusions. These protrusions can better seal the anatomical structure of the implantation site.
Claims
1. A medical implant (2) comprising a stent structure (1), one or more skirts (5, 6, 32) and a valve assembly (3); The support structure (1) has a longitudinal axis (18), a circumference, a first support structure end (11) and a second support structure end (12) opposite to the first support structure end (11), and the support structure (1) surrounds the internal volume (8), and the support structure (1) has a plurality of pillars (4) forming a unit. The first skirt (5, 6) of the one or more skirts (5, 6, 32) at least partially covers the outer side of the support structure (1), and / or the valve assembly (3) is arranged within the internal volume (8) of the support structure, the valve assembly (3) comprising one or more leaflets (31) made of biological tissue. in, The one or more skirts (5, 6, 32) and / or the one or more leaflets (31) include one or more laser marks (45) that partially penetrate the thickness of the one or more skirts (5, 6, 32) and / or the one or more leaflets (31), and the laser marks are located at the position where stitches are subsequently provided.
2. The medical implant (2) according to claim 1, wherein, The laser marking (45) is optically visible from one or both sides of the material forming one or more leaflets (31) of the skirt or valve assembly (3).
3. The medical implant (2) according to claim 1, wherein, The support structure (1) has a compressed state and can be expanded to a functional state.
4. The medical implant (2) according to claim 3, wherein, The first skirt (5, 6), which at least partially covers the outer side of the support structure (1), has a protrusion that extends radially outward along the circumference of the support structure (1) at least in the functional state.
5. The medical implant (2) according to claim 1, wherein, The medical implant (2) includes only a skirt (6) that is at least partially or completely wrapped around the first stent structure end (11) and at least partially covers the inside of the stent structure (1).
6. The medical implant (2) according to claim 1, wherein, The first skirt (5, 6) that at least partially covers the outer side of the support structure (1) is the outer skirt (5), and the one or more skirts also include an inner skirt (32) that at least partially covers the inner side of the support structure (1).
7. The medical implant (2) according to claim 1, wherein, The first skirt (5, 6) that at least partially covers the outer side of the support structure (1) has one or more pleats (70).
8. The medical implant (2) according to claim 7, wherein, The fold (70) extends in the direction from the first support structure end (11) to the second support structure end (12), or the fold (70) extends in the direction of the longitudinal axis (18), or the fold (70) bends at an angle of less than 30° relative to the longitudinal axis (18).
9. The medical implant (2) according to claim 8, wherein, The fold (70) bends at an angle of less than 20° relative to the longitudinal axis (18).
10. The medical implant (2) according to claim 8, wherein, The folds (70) have a trumpet or bagpipe shape.
11. The medical implant (2) according to claim 10, wherein, At least some or each of the trumpet-shaped or bagpipe-shaped folds form a top opening.
12. The medical implant (2) according to claim 11, wherein, At least some or each of the trumpet-shaped or bagpipe-shaped folds with a top opening also have a through hole (63).
13. The medical implant (2) according to claim 12, wherein, The through-hole is configured as a slit or a side opening.
14. The medical implant (2) according to claim 1, wherein, The one or more skirts (5, 6, 32) include an inner skirt (32) and / or an outer skirt (5), and the one or more skirts and / or one or more leaflets (31) of the valve assembly (3) are pericardial tissue.
15. The medical implant (2) according to claim 1, wherein, The medical implant (2) is a vascular implant.
16. The medical implant (2) according to claim 1, wherein, The medical implant (2) is an artificial heart valve.
17. A method for manufacturing a medical implant according to claim 1, comprising the following steps: Provides a stent structure (1), one or more skirts (5, 6, 32) and a valve assembly (3) having one or more leaflets (31), wherein the one or more skirts (5, 6, 32) include an outer skirt and / or an inner skirt (32). Multiple laser markers (45) are generated in the suture area of the outer skirt, inner skirt and / or one or more leaflets, which partially penetrate the biological tissue of the outer skirt, inner skirt and / or one or more leaflets; The support structure (1) has a longitudinal axis (18), a circumference, a first support structure end (11) and a second support structure end (12) opposite to the first support structure end (11), and the support structure (1) surrounds the internal volume (8), and the support structure (1) has a plurality of pillars (4) forming a unit. The support structure (1) is at least partially covered by the one or more skirts (5, 6, 32), such that the first skirt (5, 6) of the one or more skirts (5, 6, 32) at least partially covers the outer side of the support structure (1); The valve assembly (3) is arranged within the internal volume (8) of the stent structure and the valve assembly (3) is secured to the one or more skirts (5, 6, 32) and / or the stent structure; as well as The one or more skirts (5, 6, 32) are secured to each other and / or to the stent structure and / or valve assembly such that the first skirt (5, 6) of the one or more skirts (5, 6, 32) that at least partially covers the outside of the stent structure extends at least partially outside the stent structure (1).
18. The method according to claim 17, wherein, The first skirt (5, 6) extends at least partially radially outward along the circumference of the support structure (1).
Citation Information
Patent Citations
Method of making a prosthetic valve and valve obtained therewith
US20170065408A1
Stent-valves for valve replacement and associated methods and systems for surgery
WO2007071436A2
Stents, valved-stents and methods and systems for delivery thereof
WO2009053497A1
Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
WO2011147849A1
Artificial bioprosthetic heart valve and production method thereof
CN104799975A
